US5693343A
(en)
|
1984-03-16 |
1997-12-02 |
The United States Of America As Represented By The Secretary Of The Army |
Microparticle carriers of maximal uptake capacity by both M cells and non-M cells
|
US6309669B1
(en)
|
1984-03-16 |
2001-10-30 |
The United States Of America As Represented By The Secretary Of The Army |
Therapeutic treatment and prevention of infections with a bioactive materials encapsulated within a biodegradable-biocompatible polymeric matrix
|
USRE40786E1
(en)
|
1984-03-16 |
2009-06-23 |
The United States Of America As Represented By The Secretary Of The Army |
Vaccines against intracellular pathogens using antigens encapsulated within biodegradable-biocompatible microspheres
|
US6410056B1
(en)
|
1984-03-16 |
2002-06-25 |
The United States Of America As Represented By The Secretary Of The Army |
Chemotherapeutic treatment of bacterial infections with an antibiotic encapsulated within a biodegradable polymeric matrix
|
US6217911B1
(en)
|
1995-05-22 |
2001-04-17 |
The United States Of America As Represented By The Secretary Of The Army |
sustained release non-steroidal, anti-inflammatory and lidocaine PLGA microspheres
|
NZ217821A
(en)
*
|
1985-10-10 |
1989-07-27 |
Biotech Australia Pty Ltd |
Oral delivery system; complex of active agent and vitamin b12 or analogue thereof
|
US6024983A
(en)
*
|
1986-10-24 |
2000-02-15 |
Southern Research Institute |
Composition for delivering bioactive agents for immune response and its preparation
|
US5807832A
(en)
*
|
1987-06-09 |
1998-09-15 |
Biotech Australia Pty Limited |
Oral delivery of biologically active substances bound to vitamin B12
|
US5116612A
(en)
*
|
1987-06-23 |
1992-05-26 |
Allergy Immuno Technologies, Inc. |
Immunotherapy agents for treatment of IgE mediated allergies
|
AU639903B2
(en)
*
|
1989-01-20 |
1993-08-12 |
University Of Melbourne, The |
Fibrinolysis
|
EP0454736A4
(en)
*
|
1989-01-20 |
1993-05-12 |
The University Of Melbourne |
Fibrinolysis
|
US4990336A
(en)
*
|
1989-02-08 |
1991-02-05 |
Biosearch, Inc. |
Sustained release dosage form
|
JP2582186B2
(ja)
*
|
1989-05-04 |
1997-02-19 |
サウザン リサーチ インスティチュート |
カプセル封じ法及びその製品
|
US6126945A
(en)
*
|
1989-10-03 |
2000-10-03 |
Pharmacia Ab |
Tumor killing effects of enterotoxins, superantigens, and related compounds
|
DK546289D0
(da)
*
|
1989-11-02 |
1989-11-02 |
Danochemo As |
Carotenoidpulvere
|
CA2071867A1
(en)
*
|
1989-11-06 |
1991-05-07 |
Edith Mathiowitz |
Method for producing protein microspheres
|
EP0528859B1
(en)
*
|
1990-04-24 |
1998-01-21 |
Flustat Pty. Ltd. |
Oral vaccine comprising antigen surface-associated with red blood cells
|
US5882649A
(en)
*
|
1990-04-24 |
1999-03-16 |
Flustat Pty. Ltd. |
Oral vaccine comprising antigen surface-associated with red blood cells
|
US5780012A
(en)
*
|
1990-06-21 |
1998-07-14 |
Huland; Edith |
Method for reducing lung afflictions by inhalation of cytokine solutions
|
DE59007645D1
(de)
*
|
1990-06-21 |
1994-12-08 |
Edith Dr Huland |
Verwendung zytokinhaltiger Aerosole und zytokinhaltige Aerosole selbst.
|
DK0531497T3
(da)
*
|
1991-04-02 |
1998-03-23 |
Biotech Australia Pty Ltd |
Orale indgivelsessystemer til mikropartikler
|
AU8303691A
(en)
|
1991-04-24 |
1992-12-21 |
United States Of America, As Represented By The Secretary Of The Army, The |
Oral-intestinal vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres
|
US5283066A
(en)
*
|
1992-02-19 |
1994-02-01 |
Development Center For Biotechnology |
Method of stimulating an immune response by using a hapten
|
US5352461A
(en)
*
|
1992-03-11 |
1994-10-04 |
Pharmaceutical Discovery Corporation |
Self assembling diketopiperazine drug delivery system
|
US6235313B1
(en)
|
1992-04-24 |
2001-05-22 |
Brown University Research Foundation |
Bioadhesive microspheres and their use as drug delivery and imaging systems
|
US6197346B1
(en)
|
1992-04-24 |
2001-03-06 |
Brown Universtiy Research Foundation |
Bioadhesive microspheres and their use as drug delivery and imaging systems
|
DE69331387T2
(de)
*
|
1992-09-10 |
2002-08-22 |
Childrens Medical Center |
Biodegradierbare polymeren matrizen mit verzoegerter freisetzung von lokalanaesthetika
|
US5700485A
(en)
*
|
1992-09-10 |
1997-12-23 |
Children's Medical Center Corporation |
Prolonged nerve blockade by the combination of local anesthetic and glucocorticoid
|
US5922340A
(en)
*
|
1992-09-10 |
1999-07-13 |
Children's Medical Center Corporation |
High load formulations and methods for providing prolonged local anesthesia
|
AU4932493A
(en)
*
|
1992-09-25 |
1994-04-26 |
Dynagen, Inc. |
An immunobooster for delayed release of immunogen
|
WO1994010980A1
(en)
*
|
1992-11-16 |
1994-05-26 |
Corporation Of Mercer University |
Compositions using microencapsulated neutralizing antibodies
|
SG52402A1
(en)
*
|
1992-12-22 |
1998-09-28 |
Univ Cincinnati |
Oral administration of immunologically active biomolecules and other therapeutic proteins
|
US6090925A
(en)
|
1993-03-09 |
2000-07-18 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
US6939546B2
(en)
|
1993-05-21 |
2005-09-06 |
The United States Of America As Represented By The Secretary Of The Army |
Model for testing immunogenicity of peptides
|
US5603960A
(en)
*
|
1993-05-25 |
1997-02-18 |
O'hagan; Derek T. |
Preparation of microparticles and method of immunization
|
US5562909A
(en)
*
|
1993-07-12 |
1996-10-08 |
Massachusetts Institute Of Technology |
Phosphazene polyelectrolytes as immunoadjuvants
|
US6004534A
(en)
*
|
1993-07-23 |
1999-12-21 |
Massachusetts Institute Of Technology |
Targeted polymerized liposomes for improved drug delivery
|
WO1995003035A1
(en)
*
|
1993-07-23 |
1995-02-02 |
Massachusetts Institute Of Technology |
Polymerized liposomes with enhanced stability for oral delivery
|
AU7980794A
(en)
*
|
1993-10-22 |
1995-05-08 |
Genentech Inc. |
Methods and compositions for microencapsulation of antigens for use as vaccines
|
ES2182850T3
(es)
*
|
1993-10-22 |
2003-03-16 |
Genentech Inc |
Procedimientos y composiciones para la microencapsulacion de adyuvantes.
|
DK0724433T3
(da)
*
|
1993-10-22 |
1999-08-30 |
Genentech Inc |
Fremgangsmåde til fremstilling af mikrosfærer med et tørringstrin i fluidiseret leje
|
US6080429A
(en)
*
|
1993-10-25 |
2000-06-27 |
Genentech, Inc. |
Method for drying microspheres
|
US6913767B1
(en)
|
1993-10-25 |
2005-07-05 |
Genentech, Inc. |
Compositions for microencapsulation of antigens for use as vaccines
|
US5643605A
(en)
*
|
1993-10-25 |
1997-07-01 |
Genentech, Inc. |
Methods and compositions for microencapsulation of adjuvants
|
CN1074923C
(zh)
*
|
1993-11-19 |
2001-11-21 |
詹森药业有限公司 |
微囊密封的3-哌啶基取代的1,2-苯并异唑类和1,2-苯并异噻唑类
|
US5902565A
(en)
*
|
1993-12-24 |
1999-05-11 |
Csl Limited |
Spray dried vaccine preparation comprising aluminium adsorbed immunogens
|
US6531156B1
(en)
|
1994-04-15 |
2003-03-11 |
Temple University |
Aqueous solven encapsulation method, apparatus and microcapsules
|
US5876735A
(en)
*
|
1994-04-22 |
1999-03-02 |
Corixa Corporation |
Methods for enhancement of protective immune responses
|
US6013268A
(en)
|
1994-04-22 |
2000-01-11 |
Corixa Corporation |
Methods for enhancement of protective immune responses
|
US6855331B2
(en)
|
1994-05-16 |
2005-02-15 |
The United States Of America As Represented By The Secretary Of The Army |
Sustained release hydrophobic bioactive PLGA microspheres
|
US6447796B1
(en)
|
1994-05-16 |
2002-09-10 |
The United States Of America As Represented By The Secretary Of The Army |
Sustained release hydrophobic bioactive PLGA microspheres
|
US5571531A
(en)
*
|
1994-05-18 |
1996-11-05 |
Mcmaster University |
Microparticle delivery system with a functionalized silicone bonded to the matrix
|
US6207646B1
(en)
*
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
US20030026782A1
(en)
*
|
1995-02-07 |
2003-02-06 |
Arthur M. Krieg |
Immunomodulatory oligonucleotides
|
US5681819A
(en)
*
|
1994-12-01 |
1997-10-28 |
Oklahoma Medical Research Foundation |
Method and compositions for reducing cholesterol absorption
|
US5821226A
(en)
*
|
1994-12-01 |
1998-10-13 |
Oklahoma Medical Research Foundation |
BAL C-tail drug delivery molecules
|
US5696087A
(en)
*
|
1994-12-01 |
1997-12-09 |
Oklahoma Medical Research Foundation |
Method and compositions for reducing cholesterol absorption
|
US6902743B1
(en)
|
1995-05-22 |
2005-06-07 |
The United States Of America As Represented By The Secretary Of The Army |
Therapeutic treatment and prevention of infections with a bioactive material(s) encapuslated within a biodegradable-bio-compatable polymeric matrix
|
US7033608B1
(en)
|
1995-05-22 |
2006-04-25 |
The United States Of America As Represented By The Secretary Of The Army |
“Burst-free” sustained release poly-(lactide/glycolide) microspheres
|
DE69632569T2
(de)
|
1995-06-09 |
2005-08-18 |
Euroceltique S.A. |
Formulierungen und verfahren für eine verlängerte lokalanästhesie
|
US6248720B1
(en)
|
1996-07-03 |
2001-06-19 |
Brown University Research Foundation |
Method for gene therapy using nucleic acid loaded polymeric microparticles
|
WO1997003702A1
(en)
|
1995-07-21 |
1997-02-06 |
Brown University Research Foundation |
A method for gene therapy using nucleic acid loaded polymeric microparticles
|
US6143211A
(en)
|
1995-07-21 |
2000-11-07 |
Brown University Foundation |
Process for preparing microparticles through phase inversion phenomena
|
TR200806258T2
(tr)
|
1995-09-01 |
2008-10-21 |
Corixa Corporation |
Tüberkülozun teşhisi ve immünoterapi yolu ile önlenmesine mahsus yöntemler ve bileşikler
|
EP0862419B2
(en)
|
1995-11-09 |
2010-11-17 |
Microbiological Research Authority |
Microencapsulated dna for vaccination and gene therapy
|
US6270795B1
(en)
|
1995-11-09 |
2001-08-07 |
Microbiological Research Authority |
Method of making microencapsulated DNA for vaccination and gene therapy
|
US5985312A
(en)
*
|
1996-01-26 |
1999-11-16 |
Brown University Research Foundation |
Methods and compositions for enhancing the bioadhesive properties of polymers
|
US6368586B1
(en)
|
1996-01-26 |
2002-04-09 |
Brown University Research Foundation |
Methods and compositions for enhancing the bioadhesive properties of polymers
|
US6342218B1
(en)
|
1997-02-14 |
2002-01-29 |
Oklahoma Medical Research Foundation |
Method for treatment of SLE
|
US6207185B1
(en)
|
1996-03-22 |
2001-03-27 |
Bio-Sphere Technology |
Method for inducing a systemic immune response to an HIV antigen
|
US6015576A
(en)
*
|
1997-08-29 |
2000-01-18 |
Bio-Sphere Technology, Inc. |
Method for inducing a systemic immune response to an antigen
|
US6117449A
(en)
*
|
1996-03-22 |
2000-09-12 |
Bio-Sphere Technology, Inc. |
Method for inducing a systemic immune response to a hepatitis antigen
|
US5874064A
(en)
*
|
1996-05-24 |
1999-02-23 |
Massachusetts Institute Of Technology |
Aerodynamically light particles for pulmonary drug delivery
|
US5985309A
(en)
*
|
1996-05-24 |
1999-11-16 |
Massachusetts Institute Of Technology |
Preparation of particles for inhalation
|
US20020052310A1
(en)
|
1997-09-15 |
2002-05-02 |
Massachusetts Institute Of Technology The Penn State Research Foundation |
Particles for inhalation having sustained release properties
|
US6652837B1
(en)
|
1996-05-24 |
2003-11-25 |
Massachusetts Institute Of Technology |
Preparation of novel particles for inhalation
|
AU733867B2
(en)
|
1996-06-24 |
2001-05-31 |
Euro-Celtique S.A. |
Methods for providing safe local anesthesia
|
US5955096A
(en)
*
|
1996-06-25 |
1999-09-21 |
Brown University Research Foundation |
Methods and compositions for enhancing the bioadhesive properties of polymers using organic excipients
|
US6344202B1
(en)
*
|
1996-07-12 |
2002-02-05 |
University Of Manitoba |
DNA immunization against chlaymdia infection
|
US5980948A
(en)
*
|
1996-08-16 |
1999-11-09 |
Osteotech, Inc. |
Polyetherester copolymers as drug delivery matrices
|
US6046187A
(en)
*
|
1996-09-16 |
2000-04-04 |
Children's Medical Center Corporation |
Formulations and methods for providing prolonged local anesthesia
|
US20020182258A1
(en)
*
|
1997-01-22 |
2002-12-05 |
Zycos Inc., A Delaware Corporation |
Microparticles for delivery of nucleic acid
|
US5783567A
(en)
*
|
1997-01-22 |
1998-07-21 |
Pangaea Pharmaceuticals, Inc. |
Microparticles for delivery of nucleic acid
|
EP1837017A3
(en)
*
|
1997-01-22 |
2009-12-23 |
Eisai Inc. |
Microparticles for delivery of nucleic acid
|
EP0981624A2
(en)
|
1997-02-12 |
2000-03-01 |
Corixa Corporation |
$i(LEISHMANIA) ANTIGENS FOR USE IN THE THERAPY AND DIAGNOSIS OF LEISHMANIASIS
|
US6261562B1
(en)
|
1997-02-25 |
2001-07-17 |
Corixa Corporation |
Compounds for immunotherapy of prostate cancer and methods for their use
|
US6406705B1
(en)
|
1997-03-10 |
2002-06-18 |
University Of Iowa Research Foundation |
Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
|
PT1493439E
(pt)
|
1997-04-02 |
2012-01-10 |
Brigham & Womens Hospital |
Meio de avaliação do perfil de risco de um indivíduo para uma doença aterosclerótica
|
ZA982968B
(en)
|
1997-04-09 |
1998-10-27 |
Corixa Corp |
Compositions and methods for the treatment and diagnosis of breast cancer
|
US6060082A
(en)
|
1997-04-18 |
2000-05-09 |
Massachusetts Institute Of Technology |
Polymerized liposomes targeted to M cells and useful for oral or mucosal drug delivery
|
CA2271750C
(en)
|
1997-07-02 |
2004-04-27 |
Euro-Celtique, S.A. |
Prolonged anesthesia in joints and body spaces
|
EP1579851A3
(en)
*
|
1997-08-29 |
2009-09-02 |
Corixa Corporation |
Rapid release encapsulated bioactive agents for inducing or potentiating an immune response and methods of use thereof
|
ES2248914T3
(es)
*
|
1997-08-29 |
2006-03-16 |
Corixa Corporation |
Agentes bioactivos encapsulados de liberacion rapida que permiten inducir o potenciar una respuesta inmunitaria y metodos para utilizar los mismos.
|
US7052678B2
(en)
|
1997-09-15 |
2006-05-30 |
Massachusetts Institute Of Technology |
Particles for inhalation having sustained release properties
|
US20060165606A1
(en)
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
US6183746B1
(en)
*
|
1997-10-09 |
2001-02-06 |
Zycos Inc. |
Immunogenic peptides from the HPV E7 protein
|
US6013258A
(en)
*
|
1997-10-09 |
2000-01-11 |
Zycos Inc. |
Immunogenic peptides from the HPV E7 protein
|
US6197229B1
(en)
*
|
1997-12-12 |
2001-03-06 |
Massachusetts Institute Of Technology |
Method for high supercoiled DNA content microspheres
|
PT1042001E
(pt)
*
|
1997-12-16 |
2002-09-30 |
Chiron Corp |
Uso de microparticulas combinadas com emulsoes submicronicas oleo-em-agua
|
US7393630B2
(en)
|
1997-12-16 |
2008-07-01 |
Novartis Vaccines And Diagnostics, Inc. |
Use of microparticles combined with submicron oil-in-water emulsions
|
JP2002507387A
(ja)
|
1997-12-24 |
2002-03-12 |
コリクサ コーポレイション |
乳癌の免疫療法および診断のための化合物ならびにそれらの使用のための方法
|
KR20010041992A
(ko)
|
1998-03-18 |
2001-05-25 |
길리스 스티브 |
폐암의 치료와 진단을 위한 화합물 및 이를 위한 방법
|
US20020147143A1
(en)
|
1998-03-18 |
2002-10-10 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of lung cancer
|
KR100692227B1
(ko)
|
1998-04-07 |
2007-03-09 |
코릭사 코포레이션 |
마이코박테리움 튜베르쿨로시스 항원의 융합 단백질 및이의 용도
|
AU3555599A
(en)
|
1998-04-13 |
1999-11-01 |
Luminex Corporation |
Liquid labeling with fluorescent microparticles
|
SE9801288D0
(sv)
*
|
1998-04-14 |
1998-04-14 |
Astra Ab |
Vaccine delivery system and metod of production
|
US6406719B1
(en)
|
1998-05-13 |
2002-06-18 |
Microbiological Research Authority |
Encapsulation of bioactive agents
|
GB9810236D0
(en)
|
1998-05-13 |
1998-07-08 |
Microbiological Res Authority |
Improvements relating to encapsulation of bioactive agents
|
DE69932717T2
(de)
|
1998-05-22 |
2007-08-09 |
Ottawa Health Research Institute, Ottawa |
Methoden und produkte zur induzierung mukosaler immunität
|
JP2002518349A
(ja)
|
1998-06-18 |
2002-06-25 |
ジョンズ ホプキンス ユニバーシティ スクール オブ メディシン |
核酸デリバリー用ポリマー
|
US20030022854A1
(en)
|
1998-06-25 |
2003-01-30 |
Dow Steven W. |
Vaccines using nucleic acid-lipid complexes
|
BR9912671A
(pt)
|
1998-08-07 |
2001-05-02 |
Univ Washington |
Antìgenos imunológicos para o vìrus de herpes simples e métodos para sua utilização
|
US6264991B1
(en)
|
1998-08-18 |
2001-07-24 |
Southern Research Institute |
Compositions and methods for treating intracellular infections
|
US6956021B1
(en)
|
1998-08-25 |
2005-10-18 |
Advanced Inhalation Research, Inc. |
Stable spray-dried protein formulations
|
US7087236B1
(en)
*
|
1998-09-01 |
2006-08-08 |
Merrion Research I Limited |
Method for inducing a cell-mediated immune response and improved parenteral vaccine formulations thereof
|
ATE452651T1
(de)
|
1998-09-01 |
2010-01-15 |
Merrion Res Iii Ltd |
Orale impfstoff-zusammensetzung
|
US20030235557A1
(en)
|
1998-09-30 |
2003-12-25 |
Corixa Corporation |
Compositions and methods for WT1 specific immunotherapy
|
FR2786098B1
(fr)
|
1998-11-20 |
2003-05-30 |
Flamel Tech Sa |
Particules a base de polyaminoacide(s) et susceptibles d'etre utilisees comme vecteurs de principe(s) actif(s), suspension colloidale les comprenant et leurs procedes de fabrication
|
US20040009535A1
(en)
|
1998-11-27 |
2004-01-15 |
Celltech R&D, Inc. |
Compositions and methods for increasing bone mineralization
|
IL143531A0
(en)
|
1998-12-08 |
2002-04-21 |
Corixa Corp |
Polypeptides containing an antigenic portion of a chlamydia antigen, dna sequences encoding said polypeptides and pharmaceutical compositions and vaccines containing the same
|
US20020119158A1
(en)
|
1998-12-17 |
2002-08-29 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of ovarian cancer
|
US6579973B1
(en)
|
1998-12-28 |
2003-06-17 |
Corixa Corporation |
Compositions for the treatment and diagnosis of breast cancer and methods for their use
|
ATE407949T1
(de)
|
1998-12-30 |
2008-09-15 |
Beth Israel Hospital |
Charakterisierung der proteinfamilie von soc/crac kalziumkanälen
|
US6395714B1
(en)
|
1999-02-24 |
2002-05-28 |
Aventis Pasteur Limited |
Expressing gp140 fragment of primary HIV-1 isolate
|
ES2308976T3
(es)
|
1999-04-02 |
2008-12-16 |
Corixa Corporation |
Compuestos y metodos para la terapia y el diagnostico del cancer de pulmon.
|
US20050158856A1
(en)
*
|
1999-04-20 |
2005-07-21 |
Edelson Richard L. |
Methods for producing functional antigen presenting dendritic cells using biodegradable microparticles for delivery of antigenic materials
|
US6521431B1
(en)
*
|
1999-06-22 |
2003-02-18 |
Access Pharmaceuticals, Inc. |
Biodegradable cross-linkers having a polyacid connected to reactive groups for cross-linking polymer filaments
|
US7678364B2
(en)
|
1999-08-25 |
2010-03-16 |
Alkermes, Inc. |
Particles for inhalation having sustained release properties
|
US6749835B1
(en)
|
1999-08-25 |
2004-06-15 |
Advanced Inhalation Research, Inc. |
Formulation for spray-drying large porous particles
|
US20020009466A1
(en)
*
|
1999-08-31 |
2002-01-24 |
David J. Brayden |
Oral vaccine compositions
|
DK1207905T3
(da)
|
1999-09-03 |
2011-01-03 |
Brigham & Womens Hospital |
Fremgangsmåder og sammensætninger til behandling af inflammatorisk sygdom under anvendelse af cadherin-II modulerende midler
|
US6811783B1
(en)
|
1999-09-07 |
2004-11-02 |
Aventis Pasteur Limited |
Immunogenic compositions for protection against chlamydial infection
|
US20050100928A1
(en)
*
|
1999-09-16 |
2005-05-12 |
Zycos Inc., A Delaware Corporation |
Nucleic acids encoding polyepitope polypeptides
|
US6458387B1
(en)
*
|
1999-10-18 |
2002-10-01 |
Epic Therapeutics, Inc. |
Sustained release microspheres
|
US20050037086A1
(en)
*
|
1999-11-19 |
2005-02-17 |
Zycos Inc., A Delaware Corporation |
Continuous-flow method for preparing microparticles
|
FR2801226B1
(fr)
|
1999-11-23 |
2002-01-25 |
Flamel Tech Sa |
Suspension colloidale de particules submicroniques de vectorisation de principes actifs et son mode de preparation
|
CA2400842C
(en)
|
2000-02-23 |
2013-01-15 |
Smithkline Beecham Biologicals S.A. |
Novel compounds
|
US20040002068A1
(en)
|
2000-03-01 |
2004-01-01 |
Corixa Corporation |
Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
|
US20030129251A1
(en)
|
2000-03-10 |
2003-07-10 |
Gary Van Nest |
Biodegradable immunomodulatory formulations and methods for use thereof
|
JP2003530432A
(ja)
*
|
2000-04-12 |
2003-10-14 |
ミナーヴァ・バイオテクノロジーズ・コーポレーション |
神経変性疾患の治療
|
EP1278855B1
(en)
|
2000-04-21 |
2008-03-12 |
Corixa Corporation |
Compounds and methods for treatment and diagnosis of chlamydial infection
|
US7871598B1
(en)
|
2000-05-10 |
2011-01-18 |
Novartis Ag |
Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
|
DE60112073T2
(de)
|
2000-05-12 |
2006-04-20 |
Pharmacia & Upjohn Co. Llc, Kalamazoo |
Impfstoffzusammensetzung und verfahren zur herstellung derselben sowie verfahren zur impfung von wirbeltieren
|
EP1292285A4
(en)
*
|
2000-06-02 |
2009-07-22 |
Eisai Corp North America |
SYSTEMS FOR DISPENSING BIOACTIVE AGENTS
|
FR2814952B1
(fr)
|
2000-10-06 |
2004-01-02 |
Flamel Tech Sa |
Suspension colloidale de particules submicromiques de vectorisation de principes actifs et leur mode de preparation
|
CA2413959C
(en)
|
2000-06-20 |
2015-07-07 |
Corixa Corporation |
Fusion proteins of mycobacterium tuberculosis
|
DE60139689D1
(de)
|
2000-06-22 |
2009-10-08 |
Univ Iowa Res Found |
Kombination von CpG und Antikörpern gegen CD19,CD20,CD22 oder CD40 zur Prävention oder Behandlung von Krebs.
|
WO2002000174A2
(en)
|
2000-06-28 |
2002-01-03 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of lung cancer
|
US6565888B1
(en)
|
2000-08-23 |
2003-05-20 |
Alkermes Controlled Therapeutics, Inc. |
Methods and compositions for the targeted delivery of biologically active agents
|
US6797704B2
(en)
|
2000-10-06 |
2004-09-28 |
The Johns Hopkins University |
Systemic delivery of compounds through non-invasive bladder administration
|
ES2326209T3
(es)
|
2000-10-27 |
2009-10-05 |
Baxter Healthcare S.A. |
Produccion de microesferas.
|
EP1354196B1
(en)
*
|
2000-11-27 |
2010-09-15 |
Minerva Biotechnologies Corporation |
Diagnostics, drug screening and treatment for cancer
|
EP1985702A3
(en)
|
2000-12-08 |
2010-08-18 |
Coley Pharmaceutical GmbH |
CPG-like nucleic acids and methods of use thereof
|
CA2433335C
(en)
|
2000-12-29 |
2010-04-20 |
Advanced Inhalation Research, Inc. |
Particles for inhalation having sustained release properties
|
US20030125236A1
(en)
*
|
2000-12-29 |
2003-07-03 |
Advenced Inhalation Research, Inc. |
Particles for inhalation having rapid release properties
|
US7754208B2
(en)
|
2001-01-17 |
2010-07-13 |
Trubion Pharmaceuticals, Inc. |
Binding domain-immunoglobulin fusion proteins
|
CN1911965B
(zh)
|
2001-01-17 |
2013-05-29 |
新兴产品开发西雅图有限公司 |
结合域-免疫球蛋白融合蛋白
|
US7829084B2
(en)
|
2001-01-17 |
2010-11-09 |
Trubion Pharmaceuticals, Inc. |
Binding constructs and methods for use thereof
|
US7618939B2
(en)
*
|
2001-02-15 |
2009-11-17 |
The Board Of Trustees Of The University Of Illinois |
Compositions and methods to prevent cancer with cupredoxins
|
US7491394B2
(en)
|
2001-02-15 |
2009-02-17 |
The Board Of Trustees Of The University Of Illinois |
Cytotoxic factors for modulating cell death
|
EP1988097A1
(en)
|
2001-05-09 |
2008-11-05 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
NZ530315A
(en)
|
2001-07-10 |
2007-01-26 |
Corixa Corp |
Compositions and methods for delivery of proteins and adjuvants encapsulated in microspheres
|
CA2456806C
(en)
*
|
2001-08-08 |
2011-10-18 |
Brown University Research Foundation |
Methods for micronization of hydrophobic drugs
|
ES2307779T3
(es)
*
|
2001-08-16 |
2008-12-01 |
Baxter International Inc. |
Formulaciones de microparticulas a base de propelentes.
|
WO2003030656A2
(en)
|
2001-10-06 |
2003-04-17 |
Merial Limited |
Methods and compositions for promoting growth and innate immunity in young animals
|
EP2305314B1
(en)
|
2001-10-10 |
2015-12-23 |
ratiopharm GmbH |
Remodelling and glycoconjugation of antibodies
|
EP2279755B1
(en)
|
2001-10-10 |
2014-02-26 |
ratiopharm GmbH |
Remodelling and glycoconjugation of Fibroblast Growth Factor (FGF)
|
WO2004099231A2
(en)
|
2003-04-09 |
2004-11-18 |
Neose Technologies, Inc. |
Glycopegylation methods and proteins/peptides produced by the methods
|
AU2002340662B2
(en)
*
|
2001-11-07 |
2008-07-03 |
Tekmira Pharmaceuticals Corporation |
Mucosal adjuvants comprising an oligonucleotide and a cationic lipid
|
KR20050044523A
(ko)
|
2001-11-19 |
2005-05-12 |
벡톤 디킨슨 앤드 컴퍼니 |
입자 형태의 약제학적 조성물
|
US7182961B2
(en)
|
2001-11-20 |
2007-02-27 |
Advanced Inhalation Research, Inc. |
Particulate compositions for pulmonary delivery
|
WO2003043603A1
(en)
*
|
2001-11-20 |
2003-05-30 |
Advanced Inhalation Research, Inc. |
Particulate compositions for improving solubility of poorly soluble agents
|
WO2003049701A2
(en)
*
|
2001-12-10 |
2003-06-19 |
Spherics, Inc. |
Methods and products useful in the formation and isolation of microparticles
|
NZ533422A
(en)
|
2001-12-11 |
2008-03-28 |
Pasteur Institut |
Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation
|
WO2003053220A2
(en)
|
2001-12-17 |
2003-07-03 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
|
CA2468958C
(en)
|
2001-12-19 |
2012-07-03 |
Nektar Therapeutics |
Pulmonary delivery of aminoglycosides
|
CA2477604A1
(en)
|
2002-03-13 |
2003-09-25 |
Signum Biosciences, Inc. |
Modulation of protein methylation and phosphoprotein phosphate
|
CA2480775C
(en)
|
2002-04-04 |
2016-05-31 |
Coley Pharmaceutical Gmbh |
Immunostimulatory g,u-containing oligoribonucleotides
|
MXPA04009968A
(es)
|
2002-04-09 |
2004-12-13 |
Flamel Tech Sa |
Formulacion farmaceutica oral bajo forma de suspension acuosa de microcapsulas que permiten la liberacion modificada de principio (s) activo (s).
|
PT3072978T
(pt)
|
2002-05-09 |
2018-10-15 |
Brigham & Womens Hospital Inc |
1l1rl-1 como um marcador de doença cardiovascular
|
US20040009944A1
(en)
*
|
2002-05-10 |
2004-01-15 |
Inex Pharmaceuticals Corporation |
Methylated immunostimulatory oligonucleotides and methods of using the same
|
US20040013649A1
(en)
*
|
2002-05-10 |
2004-01-22 |
Inex Pharmaceuticals Corporation |
Cancer vaccines and methods of using the same
|
FR2840614B1
(fr)
|
2002-06-07 |
2004-08-27 |
Flamel Tech Sa |
Polyaminoacides fonctionnalises par de l'alpha-tocopherol et leurs applications notamment therapeutiques
|
DE60324678D1
(de)
|
2002-07-18 |
2008-12-24 |
Univ Washington |
N t-lymphozyten und damit identifizierte hsv-antigene
|
WO2004035028A1
(fr)
*
|
2002-10-17 |
2004-04-29 |
Gosudarstvenny Nauchny Tsentr Virusologii I Biotekhnologii 'vektor' |
Procede de production d'une forme microencapsulee d'un vaccin viral vivant
|
US20060247190A1
(en)
*
|
2002-10-21 |
2006-11-02 |
Kathleen Beach |
Compositions and methods for treating human papillomavirus mediated disease
|
EP1556077A2
(en)
|
2002-10-29 |
2005-07-27 |
Coley Pharmaceutical Group, Ltd |
Use of cpg oligonucleotides in the treatment of hepatitis c virus infection
|
JP2007531505A
(ja)
|
2002-11-27 |
2007-11-08 |
ミネルバ バイオオテクノロジーズ コーポレーション |
癌(muc1)の診断および治療のための技術および組成物
|
EP2325301B1
(en)
|
2003-02-11 |
2015-09-02 |
Shire Human Genetic Therapies, Inc. |
Diagnosis and treatment of multiple sulfatase deficiency and others using a formylglycine generating enzyme (FGE)
|
AU2004217526B2
(en)
|
2003-02-28 |
2010-02-04 |
St. Jude Children's Research Hospital Inc. |
T cell regulation
|
EP1599474B1
(en)
*
|
2003-03-04 |
2013-04-24 |
California Institute Of Technology |
Heterocyclic oligomeric compounds for DNA recognition
|
BRPI0408358A
(pt)
|
2003-03-14 |
2006-03-21 |
Neose Technologies Inc |
polìmeros hidrossolúveis ramificados e seus conjugados
|
EP1651207A4
(en)
|
2003-06-12 |
2008-10-01 |
Univ Colorado |
SYSTEMS AND METHOD FOR THE TREATMENT OF INFLAMMATORY AND PROLIFERATIVE DISEASES AND WOUNDS OF HUMANS WITH FATTY ACID SUBSTANCE CHEMICALS AND / OR GLYCOLYTIC INHIBITORS
|
EA015166B1
(ru)
|
2003-06-16 |
2011-06-30 |
Ю-Си-Би Мэньюфэкчуринг, Инк. |
Иммуногенные пептиды склеростина (sost), индуцирующие образование специфических антител
|
DE10329087B4
(de)
|
2003-06-27 |
2014-02-13 |
Biomedical International R + D Gmbh |
Antigenhaltige Mikrosphären zur Allergietherapie
|
US20050142205A1
(en)
*
|
2003-07-18 |
2005-06-30 |
Julia Rashba-Step |
Methods for encapsulating small spherical particles prepared by controlled phase separation
|
US20070092452A1
(en)
*
|
2003-07-18 |
2007-04-26 |
Julia Rashba-Step |
Methods for fabrication, uses, compositions of inhalable spherical particles
|
CN1826170B
(zh)
*
|
2003-07-18 |
2010-12-08 |
巴克斯特国际公司 |
通过受控相分离制备的小球形颗粒的制造方法、其用途和成分
|
JP2007508240A
(ja)
*
|
2003-07-22 |
2007-04-05 |
バクスター・インターナショナル・インコーポレイテッド |
低分子量有機分子の小球状粒子ならびにその調製方法および使用方法
|
US7663017B2
(en)
|
2003-07-30 |
2010-02-16 |
Institut Pasteur |
Transgenic mice having a human major histocompatability complex (MHC) phenotype, experimental uses and applications
|
JP2007502991A
(ja)
|
2003-08-20 |
2007-02-15 |
バイオサイト インコーポレイテッド |
生物活性ナトリウム利尿ペプチドを測定するための、およびその治療可能性を向上させるための方法および組成物
|
US20060173171A1
(en)
*
|
2003-08-26 |
2006-08-03 |
Bamdad Cynthia C |
Techniques and compositions for diagnosis and treatment of cancer (muci)
|
CA2542099A1
(en)
*
|
2003-10-11 |
2005-04-21 |
Inex Pharmaceuticals Corporation |
Methods and compositions for enhancing innate immunity and antibody dependent cellular cytotoxicity
|
EP1697399B1
(en)
|
2003-12-12 |
2016-11-23 |
GOVERNMENT OF THE UNITED STATES OF AMERICA, as repr. by THE SECR. OF THE DEPT. OF HEALTH AND HUMAN SERVICES AND HIS SUCCESSORS |
A human cytotoxic t-lymphocyte epitope and its agonist epitope from the non-variable number of tandem repeat sequence of muc-1
|
EP2248895B8
(en)
|
2003-12-19 |
2016-09-21 |
Autotelic LLC |
Combination therapy associating a TGF-beta antagonist with a chemotherapeutic agent
|
US7452730B2
(en)
*
|
2004-01-16 |
2008-11-18 |
California Institute Of Technology |
DNA-binding polymers
|
EP1568383A3
(en)
|
2004-02-27 |
2005-11-16 |
Antisense Pharma GmbH |
Use of an oligonucleotide or its active derivative for the preparation of a pharmaceutical composition for inhibiting the formation of metastases in cancer treatment
|
EP1722823A2
(en)
*
|
2004-02-27 |
2006-11-22 |
Antisense Pharma GmbH |
Pharmaceutical composition
|
AU2005236068C1
(en)
|
2004-04-21 |
2012-08-30 |
Beth Israel Deaconess Medical Center, Inc. |
Poly-N-acetyl glucosamine (PNAG/DPNAG)-binding peptides and methods of use thereof
|
US20050239723A1
(en)
*
|
2004-04-27 |
2005-10-27 |
Amin Avinash N |
Compositions and methods useful for treatment of acne
|
EP1758558B1
(en)
|
2004-05-12 |
2013-10-16 |
Baxter International Inc. |
Oligonucleotide-containing microspheres, their use for the manufacture of a medicament for treating diabetes type 1
|
AU2005244840C1
(en)
*
|
2004-05-12 |
2012-05-10 |
Baxter Healthcare S.A. |
Microspheres comprising protein and showing injectability at high concentrations of said agent
|
US8728525B2
(en)
|
2004-05-12 |
2014-05-20 |
Baxter International Inc. |
Protein microspheres retaining pharmacokinetic and pharmacodynamic properties
|
DE602005009954D1
(de)
|
2004-05-12 |
2008-11-06 |
Baxter Int |
Nukleinsäure-mikrokügelchen, ihre herstellung und abgabe
|
AU2005285513B2
(en)
|
2004-05-25 |
2011-02-24 |
Oregon Health And Science University |
SIV and HIV vaccination using RhCMV- and HCMV-based vaccine vectors
|
US20060014285A1
(en)
*
|
2004-07-14 |
2006-01-19 |
Eldridge Gary R |
Methods and compositions for inhibiting biofilms
|
US20060264411A1
(en)
*
|
2005-05-20 |
2006-11-23 |
Eldridge Gary R |
Control of biofilm formation
|
WO2006019906A1
(en)
|
2004-07-14 |
2006-02-23 |
The Regents Of The University Of California |
Biomarker for early detection of ovarian cancer
|
US7604978B2
(en)
*
|
2004-07-14 |
2009-10-20 |
Sequoia Sciences, Inc. |
Inhibition of biofilm formation
|
ES2475207T3
(es)
|
2004-07-15 |
2014-07-10 |
Tetralogic Pharmaceuticals Corporation |
Compuestos de unión a IAP
|
EP2298807A3
(en)
|
2004-07-30 |
2011-05-18 |
Rinat Neuroscience Corp. |
Antibodies directed against amyloid-beta peptide and methods using same
|
US9132116B2
(en)
|
2004-08-02 |
2015-09-15 |
Willowcroft Pharm Inc. |
Mast cell stabilizers to prevent or treat laminitis
|
CN101106997A
(zh)
|
2004-08-17 |
2008-01-16 |
约翰·霍普金斯大学 |
Pde5抑制剂组合物及治疗心脏病征候的方法
|
JP2008511678A
(ja)
*
|
2004-09-02 |
2008-04-17 |
イェール ユニバーシティ |
マイクロrnaによるオンコジーンの調節
|
US20080064680A1
(en)
*
|
2004-09-14 |
2008-03-13 |
Bamdad Cynthia C |
Methods for Diagnosis and Treatment of Cancer
|
CA2580078A1
(en)
|
2004-09-14 |
2006-03-23 |
Gary R. Eldridge |
Compounds, compositions and methods for controlling biofilms and bacterial infections
|
RU2419628C2
(ru)
*
|
2004-09-22 |
2011-05-27 |
ГлаксоСмитКлайн Байолоджикалз с.а. |
Иммуногенная композиция для применения в вакцинации против стафилококков
|
WO2006034454A1
(en)
*
|
2004-09-23 |
2006-03-30 |
The Trustees Of The University Of Princeton |
Bcl-2 family member and bh-3 only proteins for use in development of peptidomimetics
|
ES2439229T3
(es)
|
2004-10-06 |
2014-01-22 |
The Brigham And Women's Hospital, Inc. |
Relevancia de niveles logrados de marcadores de inflamación sistémica tras el tratamiento
|
DK3312272T3
(da)
|
2004-10-08 |
2019-12-02 |
Us Gov Health & Human Services |
Modulering af replikationstilpasning ved brug a mindre optrædende synonyme kodoner
|
US9492400B2
(en)
|
2004-11-04 |
2016-11-15 |
Massachusetts Institute Of Technology |
Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals
|
CN101115475A
(zh)
|
2004-12-10 |
2008-01-30 |
塔利马治疗公司 |
用于治疗指甲单位病症的组合物和方法
|
US20060275230A1
(en)
|
2004-12-10 |
2006-12-07 |
Frank Kochinke |
Compositions and methods for treating conditions of the nail unit
|
US8137907B2
(en)
*
|
2005-01-03 |
2012-03-20 |
Cold Spring Harbor Laboratory |
Orthotopic and genetically tractable non-human animal model for liver cancer and the uses thereof
|
ES2449195T3
(es)
|
2005-01-10 |
2014-03-18 |
Ratiopharm Gmbh |
Factor estimulante de colonias de granulocitos glicopegilado
|
US7923041B2
(en)
|
2005-02-03 |
2011-04-12 |
Signum Biosciences, Inc. |
Compositions and methods for enhancing cognitive function
|
US8221804B2
(en)
|
2005-02-03 |
2012-07-17 |
Signum Biosciences, Inc. |
Compositions and methods for enhancing cognitive function
|
US8841259B2
(en)
*
|
2005-02-24 |
2014-09-23 |
Joslin Diabetes Center |
Compositions and methods for treating vascular permeability
|
BRPI0607988A2
(pt)
|
2005-02-25 |
2009-10-27 |
Tetralogic Pharmaceuticals |
composto, composição farmacêutica, e método para induzir apoptose em uma célula
|
US7851189B2
(en)
*
|
2005-03-07 |
2010-12-14 |
Boston Scientific Scimed, Inc. |
Microencapsulated compositions for endoluminal tissue engineering
|
EP1701165A1
(en)
|
2005-03-07 |
2006-09-13 |
Johannes Dr. Coy |
Therapeutic and diagnostic uses of TKTL1 and inhibitors and activators thereof
|
ES2720288T3
(es)
|
2005-03-30 |
2019-07-19 |
Minerva Biotechnologies Corp |
Proliferación de células que expresan MUC1
|
JP2008543276A
(ja)
|
2005-03-30 |
2008-12-04 |
ミネルバ バイオテクノロジーズ コーポレーション |
Muc1発現細胞の増殖
|
EP2392349A3
(en)
|
2005-03-31 |
2012-01-18 |
GlaxoSmithKline Biologicals S.A. |
Vaccines against chlamydial infection
|
US20060228384A1
(en)
*
|
2005-04-06 |
2006-10-12 |
Sequoia Sciences, Inc. |
Control of biofilm with a biofilm inhibitor
|
EP1871795A4
(en)
|
2005-04-08 |
2010-03-31 |
Biogenerix Ag |
COMPOSITIONS AND METHOD FOR PRODUCING GLYCOSYLATION MUTANTS OF A PROTEASE-RESISTANT HUMAN GROWTH HORMONE
|
CN101448517A
(zh)
|
2005-04-19 |
2009-06-03 |
伊莱利利公司 |
用于疾病免疫干预的单价和多价合成多糖抗原
|
UY29504A1
(es)
|
2005-04-29 |
2006-10-31 |
Rinat Neuroscience Corp |
Anticuerpos dirigidos contra el péptido amiloide beta y métodos que utilizan los mismos.
|
ES2381492T3
(es)
|
2005-04-29 |
2012-05-28 |
Glaxosmithkline Biologicals Sa |
Procedimiento de prevención o tratamiento de infección por M. tuberculosis
|
ZA200709237B
(en)
|
2005-05-05 |
2009-04-29 |
Antisense Pharma Gmbh |
Dosage of oligonucleotides
|
US20080193543A1
(en)
*
|
2005-05-17 |
2008-08-14 |
Brown University Research Foundation |
Drug Delivery Formulations For Targeted Delivery
|
US8354384B2
(en)
*
|
2005-06-23 |
2013-01-15 |
Yale University |
Anti-aging micrornas
|
ATE530569T1
(de)
|
2005-07-01 |
2011-11-15 |
Forsyth Dental In Ry For Children Fa |
Assays zum nachweis von tuberkulose- antigenen, und impfstoffe
|
US20070014739A1
(en)
*
|
2005-07-14 |
2007-01-18 |
Eldridge Gary R |
Compositions and methods for controlling biofilms and bacterial infections
|
RU2486204C2
(ru)
*
|
2005-07-22 |
2013-06-27 |
Уай'З Терапьютикс Ко., Лтд. |
Антитела против сd26 и способы их применения
|
UA97469C2
(uk)
|
2005-07-25 |
2012-02-27 |
Емерджент Продакт Дівелопмент Сіетл, Елелсі |
Гуманізована специфічна до cd37 зв'язувальна молекула імуноглобуліну
|
AU2006272497B2
(en)
|
2005-07-27 |
2012-07-19 |
University Of Florida Research Foundation, Inc. |
Small compounds that correct protein misfolding and uses thereof
|
EP1913398A2
(en)
*
|
2005-08-09 |
2008-04-23 |
Tetralogic Pharmaceuticals Corporation |
Treatment of proliferative disorders
|
US20100256046A1
(en)
*
|
2009-04-03 |
2010-10-07 |
Tetralogic Pharmaceuticals Corporation |
Treatment of proliferative disorders
|
TW201402124A
(zh)
|
2005-08-19 |
2014-01-16 |
Array Biopharma Inc |
作為類鐸受體(toll-like receptor)調節劑之8-經取代苯并氮雜呯
|
US8507439B2
(en)
|
2005-08-29 |
2013-08-13 |
Angela Shashoua |
Neuroprotective and neurorestorative method and compositions
|
US20080021198A1
(en)
*
|
2005-10-12 |
2008-01-24 |
Yigong Shi |
Modulators of protein phosphatase 2A and PP2A methyl esterase
|
US8658608B2
(en)
*
|
2005-11-23 |
2014-02-25 |
Yale University |
Modified triple-helix forming oligonucleotides for targeted mutagenesis
|
CA2630738C
(en)
|
2005-11-25 |
2013-09-03 |
Coley Pharmaceutical Gmbh |
Immunostimulatory oligoribonucleotides
|
JP2009518308A
(ja)
*
|
2005-12-01 |
2009-05-07 |
ユニヴァーシティ オヴ ピッツバーグ オヴ ザ コモンウェルス システム オヴ ハイアー エデュケーション |
アポトーシスを阻害するための化合物及び方法
|
US9267937B2
(en)
|
2005-12-15 |
2016-02-23 |
Massachusetts Institute Of Technology |
System for screening particles
|
US8859209B2
(en)
*
|
2006-01-12 |
2014-10-14 |
Carviar Aps |
Reimmunization and antibody design
|
WO2007082105A2
(en)
|
2006-01-16 |
2007-07-19 |
Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Chlamydia vaccine
|
WO2007109583A2
(en)
*
|
2006-03-17 |
2007-09-27 |
The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services |
Compositions and methods for prevention or treatment of neoplastic disease in a mammalian subject
|
ES2776100T3
(es)
|
2006-03-31 |
2020-07-29 |
Massachusetts Inst Technology |
Sistema para el suministro dirigido de agentes terapéuticos
|
US8524454B2
(en)
|
2006-04-07 |
2013-09-03 |
The Research Foundation Of State University Of New York |
Transcobalamin receptor polypeptides, nucleic acids, and modulators thereof, and related methods of use in modulating cell growth and treating cancer and cobalamin deficiency
|
US8859233B2
(en)
*
|
2006-05-02 |
2014-10-14 |
Carviar Aps |
Method for immunizing an avian species
|
US10522240B2
(en)
|
2006-05-03 |
2019-12-31 |
Population Bio, Inc. |
Evaluating genetic disorders
|
US7702468B2
(en)
|
2006-05-03 |
2010-04-20 |
Population Diagnostics, Inc. |
Evaluating genetic disorders
|
NZ573646A
(en)
|
2006-06-12 |
2012-04-27 |
Wyeth Llc |
Single-chain multivalent binding proteins with effector function
|
AU2007263281B2
(en)
|
2006-06-20 |
2012-12-06 |
Transgene S.A. |
Recombinant viral vaccine
|
US9381477B2
(en)
|
2006-06-23 |
2016-07-05 |
Massachusetts Institute Of Technology |
Microfluidic synthesis of organic nanoparticles
|
CL2007002166A1
(es)
*
|
2006-07-24 |
2008-01-25 |
Tetralogic Pharm Corp |
Compuestos derivados de heterociclos de nitrogeno, antagonistas de los inhibidores de las proteinas de la apoptosis; sus composiciones farmaceuticas; y uso de dichos compuestos para el tratamiento del cancer.
|
US20100143499A1
(en)
*
|
2006-07-24 |
2010-06-10 |
Tetralogic Pharmaceuticals Corporation |
Dimeric iap inhibitors
|
WO2008014240A2
(en)
|
2006-07-24 |
2008-01-31 |
Tetralogic Pharmaceuticals Corporation |
Dimeric iap inhibitors
|
WO2008014263A2
(en)
|
2006-07-24 |
2008-01-31 |
Tetralogic Pharmaceuticals Corporation |
Dimeric iap antagonists
|
US20100056495A1
(en)
*
|
2006-07-24 |
2010-03-04 |
Tetralogic Pharmaceuticals Corporation |
Dimeric iap inhibitors
|
MX2009001226A
(es)
|
2006-08-04 |
2009-03-20 |
Baxter Int |
Composicion basada en microesferas para prevenir y/o revertir la diabetes autoinmune de nuevo inicio.
|
US20080153773A1
(en)
*
|
2006-08-08 |
2008-06-26 |
Yigong Shi |
Modulators of phosphotyrosyl phosphatase activator
|
EP2468300B1
(en)
|
2006-09-26 |
2017-12-20 |
Infectious Disease Research Institute |
Vaccine composition containing synthetic adjuvant
|
US20090181078A1
(en)
|
2006-09-26 |
2009-07-16 |
Infectious Disease Research Institute |
Vaccine composition containing synthetic adjuvant
|
DK2068907T3
(da)
|
2006-10-04 |
2018-01-15 |
Novo Nordisk As |
Glycerol-bundne pegylerede sukkere og glycopeptider
|
WO2008147426A2
(en)
*
|
2006-10-04 |
2008-12-04 |
The Brigham And Women's Hospital, Inc. |
Methods and compositions for immunomodulation
|
WO2008060791A2
(en)
*
|
2006-10-13 |
2008-05-22 |
The Trustees Of The University Of Princeton |
Modulators of protein phosphatase 2a
|
RU2373957C2
(ru)
|
2006-10-13 |
2009-11-27 |
Александр Метталинович Тишин |
Носитель для лекарственных средств и биологически активных веществ для лечения и диагностики и применение его для создания лекарственных средств и способа регулируемой управляемой доставки лекарственного средства или биологически активного вещества с регулируемой десорбцией его
|
US7645616B2
(en)
*
|
2006-10-20 |
2010-01-12 |
The University Of Hong Kong |
Use of lipocalin-2 as a diagnostic marker and therapeutic target
|
US8202967B2
(en)
|
2006-10-27 |
2012-06-19 |
Boehringer Ingelheim Vetmedica, Inc. |
H5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use
|
US9217129B2
(en)
|
2007-02-09 |
2015-12-22 |
Massachusetts Institute Of Technology |
Oscillating cell culture bioreactor
|
WO2008109773A2
(en)
*
|
2007-03-06 |
2008-09-12 |
Cornell Research Foundation, Inc. |
Chronic obstructive pulmonary disease susceptibility and related compositions and methods
|
WO2008116216A1
(en)
*
|
2007-03-22 |
2008-09-25 |
Medical College Of Georgia Research Institute, Inc. |
Compositions and methods for inhibiting cancer metastasis
|
US7960139B2
(en)
|
2007-03-23 |
2011-06-14 |
Academia Sinica |
Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
|
WO2008122039A2
(en)
*
|
2007-04-02 |
2008-10-09 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Selenocysteine mediated hybrid antibody molecules
|
WO2008124632A1
(en)
|
2007-04-04 |
2008-10-16 |
Massachusetts Institute Of Technology |
Amphiphilic compound assisted nanoparticles for targeted delivery
|
SI2644205T1
(sl)
|
2007-04-12 |
2018-11-30 |
The Brigham And Women's Hospital, Inc. |
Ciljanje ABCB5 za zdravljenje raka
|
WO2008131129A2
(en)
|
2007-04-17 |
2008-10-30 |
Baxter International Inc. |
Nucleic acid microparticles for pulmonary delivery
|
US20100179158A1
(en)
*
|
2007-04-20 |
2010-07-15 |
Hoffman Charles S |
Inhibitors of cyclic amp phosphodiesterases
|
WO2008137747A1
(en)
|
2007-05-02 |
2008-11-13 |
The Regents Of The University Of Michigan |
Nanoemulsion therapeutic compositions and methods of using the same
|
KR20100010509A
(ko)
*
|
2007-05-17 |
2010-02-01 |
콜레이 파마시티컬 그룹, 인코포레이티드 |
면역자극 효과를 갖는 a 클래스 올리고뉴클레오타이드
|
EP2166844A4
(en)
*
|
2007-06-07 |
2013-09-04 |
Evonik Corp |
DOSAGE FORMS WITH EXTENDED ACTION AND REDUCED MASS
|
ES2537349T3
(es)
|
2007-06-08 |
2015-06-05 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Métodos para determinar un subtipo de carcinoma hepatocelular
|
EP2190440A1
(en)
|
2007-08-13 |
2010-06-02 |
Pfizer Inc. |
Combination motif immune stimulatory oligonucleotides with improved activity
|
US8932558B2
(en)
*
|
2007-10-05 |
2015-01-13 |
Plaxgen Inc |
Multi-subunit biological complexes for treatment of plaque-associated diseases
|
AU2008314647B2
(en)
|
2007-10-12 |
2013-03-21 |
Massachusetts Institute Of Technology |
Vaccine nanotechnology
|
US8619257B2
(en)
|
2007-12-13 |
2013-12-31 |
Kimberley-Clark Worldwide, Inc. |
Recombinant bacteriophage for detection of nosocomial infection
|
US20090274682A1
(en)
*
|
2008-02-05 |
2009-11-05 |
The Trustees Of Princeton University |
Demethylation and inactivation of protein phosphatase 2a
|
US20090233858A1
(en)
*
|
2008-02-26 |
2009-09-17 |
The Trustees Of Princeton University |
Structure of a protein phosphatase 2a holoenzyme: insights into tau dephosphorylation
|
EP2257626A2
(en)
*
|
2008-03-01 |
2010-12-08 |
Abraxis BioScience, LLC |
Treatment, diagnostic, and method for discovering antagonist using sparc specific mirnas
|
CN102144163A
(zh)
|
2008-04-10 |
2011-08-03 |
麻省理工学院 |
关于鉴定和使用靶向癌症干细胞的试剂的方法
|
AU2009234389B2
(en)
|
2008-04-10 |
2014-08-21 |
Cell Signaling Technology, Inc. |
Compositions and methods for detecting EGFR mutations in cancer
|
NZ603059A
(en)
|
2008-04-11 |
2014-07-25 |
Emergent Product Dev Seattle |
Cd37 immunotherapeutic and combination with bifunctional chemotherapeutic thereof
|
US20100227853A1
(en)
*
|
2008-04-18 |
2010-09-09 |
Trustees Of Boston College |
Inhibitors of cyclic amp phosphodiesterases
|
DK2982753T3
(da)
|
2008-04-18 |
2018-09-03 |
Baxter Int |
Mikrosfære-baseret sammensætning til at forebygge og/eller reversere nystartet autoimmun diabetes
|
EP2281043B1
(en)
|
2008-04-25 |
2013-03-13 |
Innate Pharma |
Improved tlr3 agonist compositions
|
CA2723716A1
(en)
*
|
2008-05-07 |
2009-11-12 |
Abraxis Bioscience, Llc |
Enhancement of drug therapy by mirna
|
EP2123748A1
(en)
|
2008-05-20 |
2009-11-25 |
Institut Pasteur |
2'-5'-oligoadenylate synthetase 3 for preventing and treating positive-sense single-stranded rna virus infection
|
EP2303888B1
(en)
|
2008-06-12 |
2015-05-06 |
President and Fellows of Harvard College |
Compounds for antimicrobial intervention
|
US8680020B2
(en)
|
2008-07-15 |
2014-03-25 |
Academia Sinica |
Glycan arrays on PTFE-like aluminum coated glass slides and related methods
|
CA2737146A1
(en)
|
2008-07-25 |
2010-01-28 |
The Regents Of The University Of Colorado |
Clip inhibitors and methods of modulating immune function
|
US9273136B2
(en)
*
|
2008-08-04 |
2016-03-01 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Fully human anti-human NKG2D monoclonal antibodies
|
US8323685B2
(en)
*
|
2008-08-20 |
2012-12-04 |
Baxter International Inc. |
Methods of processing compositions containing microparticles
|
US8323615B2
(en)
|
2008-08-20 |
2012-12-04 |
Baxter International Inc. |
Methods of processing multi-phasic dispersions
|
US8367427B2
(en)
|
2008-08-20 |
2013-02-05 |
Baxter International Inc. |
Methods of processing compositions containing microparticles
|
JP2012503004A
(ja)
|
2008-09-17 |
2012-02-02 |
テトラロジック ファーマシューティカルズ コーポレーション |
Iap阻害剤
|
EP2331103A1
(en)
*
|
2008-09-22 |
2011-06-15 |
The U.S.A. As Represented By The Secretary, Department Of Health And Human Services |
Nuclear factor kappa b pathway inhibitor composition and use of same
|
AU2009302241B2
(en)
*
|
2008-10-08 |
2015-10-29 |
Xgene Pharmaceutical Inc. |
GABA conjugates and methods of use thereof
|
EP4201421A1
(en)
|
2008-10-09 |
2023-06-28 |
Minerva Biotechnologies Corporation |
Method for inducing pluripotency in cells
|
US8277812B2
(en)
|
2008-10-12 |
2012-10-02 |
Massachusetts Institute Of Technology |
Immunonanotherapeutics that provide IgG humoral response without T-cell antigen
|
US8591905B2
(en)
|
2008-10-12 |
2013-11-26 |
The Brigham And Women's Hospital, Inc. |
Nicotine immunonanotherapeutics
|
US20110287034A1
(en)
|
2008-11-14 |
2011-11-24 |
The Brigham And Womens Hospital, Inc. |
Therapeutic and diagnostic methods relating to cancer stem cells
|
CA2743904A1
(en)
|
2008-11-17 |
2010-05-20 |
The Regents Of The University Of Michigan |
Cancer vaccine compositions and methods of using the same
|
WO2010075303A1
(en)
|
2008-12-23 |
2010-07-01 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Splicing factors with a puf protein rna-binding domain and a splicing effector domain and uses of same
|
WO2010075417A1
(en)
|
2008-12-23 |
2010-07-01 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Survivin specific t cell receptor for treating cancer
|
US8309356B2
(en)
*
|
2009-04-01 |
2012-11-13 |
Yale University |
Pseudocomplementary oligonucleotides for targeted gene therapy
|
ES2713349T3
(es)
|
2009-04-15 |
2019-05-21 |
Bmg Pharma S P A |
Composiciones de sal mineral-ácido sulfónico y procedimientos de uso
|
US9316646B2
(en)
|
2009-04-23 |
2016-04-19 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Anti-human ROR1 antibodies
|
EP3375441A1
(en)
|
2009-04-30 |
2018-09-19 |
The U.S.A. as represented by the Secretary, Department of Health and Human Services |
Schweinfurthins and uses thereof
|
HUE025765T2
(en)
|
2009-05-14 |
2016-05-30 |
Bayer Ip Gmbh |
Increased immune response in bird species
|
US8877199B2
(en)
|
2009-05-15 |
2014-11-04 |
The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services |
B cell surface reactive antibodies
|
CN102481312B
(zh)
|
2009-06-05 |
2015-07-15 |
传染性疾病研究院 |
合成的吡喃葡萄糖脂佐剂
|
WO2010144611A2
(en)
*
|
2009-06-10 |
2010-12-16 |
3-V Biosciences, Inc. |
Antivirals that target transporters, carriers, and ion channels
|
IN2012DN00352A
(da)
|
2009-06-16 |
2015-08-21 |
Bikam Pharmaceuticals Inc |
|
JP6110140B2
(ja)
|
2009-06-16 |
2017-04-05 |
ザ リージェンツ オブ ザ ユニヴァシティ オブ ミシガン |
ナノエマルションワクチン
|
US8283372B2
(en)
*
|
2009-07-02 |
2012-10-09 |
Tetralogic Pharmaceuticals Corp. |
2-(1H-indol-3-ylmethyl)-pyrrolidine dimer as a SMAC mimetic
|
WO2011011092A1
(en)
|
2009-07-22 |
2011-01-27 |
University Of Massachusetts |
Methods and compositions to reduce oxidative stress
|
PE20121495A1
(es)
|
2009-07-30 |
2012-11-19 |
Antisense Pharma Gmbh |
Combinacion de un agente quimioterapeutico y un inhibidor del sistema tgf-beta
|
EP2292260A1
(en)
|
2009-08-13 |
2011-03-09 |
Institut Pasteur |
Use of mycobacterium bovis BCG killed by extended freeze drying (EFD) for preventing or treating atherosclerosis
|
EP2287304A1
(en)
|
2009-08-17 |
2011-02-23 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Novel treatment of patients after stent implantation or balloon dilatation and novel drug eluting stents
|
RU2580320C2
(ru)
|
2009-08-18 |
2016-04-10 |
Вентиркс Фармасьютикалз, Инк. |
Замещенные бензоазепины в качестве модуляторов toll-подобного рецептора
|
US8691809B2
(en)
|
2009-08-18 |
2014-04-08 |
Ventirx Pharmaceuticals, Inc. |
Substituted benzoazepines as toll-like receptor modulators
|
WO2011034950A1
(en)
|
2009-09-16 |
2011-03-24 |
Vaxart, Inc. |
Immunization strategy to prevent h1n1 infection
|
JP5934099B2
(ja)
|
2009-10-01 |
2016-06-15 |
アメリカ合衆国 |
抗血管内皮増殖因子受容体−2キメラ抗原受容体及び癌の治療のためのその使用
|
US20110104138A1
(en)
|
2009-11-03 |
2011-05-05 |
Institut Pasteur |
Use of the innate immunity gene oasl for preventing or treating infection with negative strand rna viruses
|
US9321999B2
(en)
|
2009-11-19 |
2016-04-26 |
Solis Biodyne Oü |
Compositions for increasing polypeptide stability and activity, and related methods
|
US10087236B2
(en)
|
2009-12-02 |
2018-10-02 |
Academia Sinica |
Methods for modifying human antibodies by glycan engineering
|
US11377485B2
(en)
|
2009-12-02 |
2022-07-05 |
Academia Sinica |
Methods for modifying human antibodies by glycan engineering
|
CN102812023A
(zh)
|
2010-01-13 |
2012-12-05 |
韩国巴斯德研究所 |
抗感染吡啶并(1,2-a)嘧啶类
|
DK2528621T3
(da)
|
2010-01-27 |
2017-01-02 |
Glaxosmithkline Biologicals Sa |
Modificerede tuberkuloseantigener
|
US9556248B2
(en)
|
2010-03-19 |
2017-01-31 |
The Board Of Trustees Of The Leland Stanford Junior University |
Hepatocyte growth factor fragments that function as potent met receptor agonists and antagonists
|
WO2011130332A1
(en)
|
2010-04-12 |
2011-10-20 |
Academia Sinica |
Glycan arrays for high throughput screening of viruses
|
WO2011133803A1
(en)
|
2010-04-21 |
2011-10-27 |
Helix Therapeutics, Inc. |
Compositions and methods for targeted inactivation of hiv cell surface receptors
|
WO2011133802A1
(en)
|
2010-04-21 |
2011-10-27 |
Helix Therapeutics, Inc. |
Compositions and methods for treatment of lysosomal storage disorders
|
EP3138915A1
(en)
|
2010-05-04 |
2017-03-08 |
The Brigham and Women's Hospital, Inc. |
Detection and treatment of fibrosis
|
WO2011138032A2
(en)
|
2010-05-05 |
2011-11-10 |
Artemev, Timur |
Universal influenza vaccines and methods for their generation
|
US8658603B2
(en)
|
2010-06-16 |
2014-02-25 |
The Regents Of The University Of Michigan |
Compositions and methods for inducing an immune response
|
WO2012012627A1
(en)
|
2010-07-22 |
2012-01-26 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Method of preventing or treating viral infection
|
EP2601609B1
(en)
|
2010-08-02 |
2017-05-17 |
Population Bio, Inc. |
Compositions and methods for discovery of causative mutations in genetic disorders
|
AR083533A1
(es)
|
2010-10-22 |
2013-03-06 |
Boehringer Ingelheim Vetmed |
Proteinas de hemaglutinina 5 (h5) para el tratamiento y prevencion de las infecciones de gripe
|
AU2011332815A1
(en)
|
2010-11-23 |
2013-05-30 |
Presage Biosciences, Inc. |
Therapeutic methods and compositions for solid delivery
|
CA2818992C
(en)
|
2010-12-01 |
2021-05-04 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Chimeric rabbit/human ror1 antibodies
|
WO2012084951A1
(en)
|
2010-12-22 |
2012-06-28 |
Bayer Animal Health Gmbh |
Enhanced immune response in bovine species
|
CN106749023A
(zh)
|
2011-01-12 |
2017-05-31 |
帆德制药股份有限公司 |
作为toll样受体调节剂的取代的苯并氮杂卓
|
US20140088085A1
(en)
|
2011-01-12 |
2014-03-27 |
Array Biopharma, Inc |
Substituted Benzoazepines As Toll-Like Receptor Modulators
|
AU2012212023B9
(en)
|
2011-02-03 |
2017-01-12 |
Mirna Therapeutics, Inc. |
Synthetic mimics of miR-34
|
CA2826043A1
(en)
|
2011-02-03 |
2012-08-09 |
Mirna Therapeutics, Inc. |
Synthetic mimics of mir-124
|
BR112013022761B8
(pt)
|
2011-03-08 |
2023-01-17 |
3 V Biosciences Inc |
Compostos moduladores heterocíclicos de síntese de lipídios, suas composições e usos
|
HUE037095T2
(hu)
|
2011-03-09 |
2018-08-28 |
Cell Signaling Technology Inc |
Eljárások és reagensek monoklonális ellenanyagok elõállítására
|
PT3459560T
(pt)
|
2011-04-08 |
2021-05-24 |
Us Health |
Recetores de antigénio quimérico variante iii de recetor de fator de crescimento antiepidérmico e utilização dos mesmos para o tratamento de cancro
|
EA027236B1
(ru)
|
2011-04-08 |
2017-07-31 |
Иммьюн Дизайн Корп. |
Иммуногенные композиции и способы применения таких композиций для индукции гуморального и клеточного иммунного ответа
|
CN105148285B
(zh)
|
2011-04-21 |
2019-02-12 |
塔夫茨大学信托人 |
用于活性试剂稳定化的方法和组合物
|
AU2012262014B2
(en)
|
2011-06-01 |
2016-07-14 |
Janus Biotherapeutics, Inc. |
Novel immune system modulators
|
EP2713737B1
(en)
|
2011-06-01 |
2016-04-20 |
Janus Biotherapeutics, Inc. |
Novel immune system modulators
|
BR112013032199A2
(pt)
|
2011-06-14 |
2017-12-12 |
Bikam Pharmaceuticals Inc |
ligantes de ligação à opsina, composições e métodos de utilização
|
KR102033185B1
(ko)
|
2011-06-17 |
2019-10-16 |
유니버시티 오브 테네시 리서치 파운데이션 |
그룹 a 스트렙토콕쿠스 다가 백신
|
US20150030586A1
(en)
|
2011-06-21 |
2015-01-29 |
Sarah Ellen Warren |
Compositions and methods for the therapy and diagnosis of cancer
|
US8759313B2
(en)
|
2011-08-03 |
2014-06-24 |
The Charlotte-Mecklenburg Hospital Authority |
Treatment of fibrosis using microRNA 19b
|
CA2842321C
(en)
|
2011-07-18 |
2022-05-03 |
President And Fellows Of Harvard College |
Engineered microbe-targeting molecules and uses thereof
|
US10765654B2
(en)
|
2011-07-19 |
2020-09-08 |
University Of Vermont And State Agricultural College |
Methods and compounds for treating cancer
|
US8324264B1
(en)
|
2011-07-22 |
2012-12-04 |
Sequoia Sciences, Inc. |
Inhibitors of bacterial biofilms and related methods
|
AR088028A1
(es)
|
2011-08-15 |
2014-05-07 |
Boehringer Ingelheim Vetmed |
Proteinas h5, de h5n1 para un uso medicinal
|
WO2013052550A2
(en)
|
2011-10-04 |
2013-04-11 |
Janus Biotherapeutics, Inc. |
Novel imidazole quinoline-based immune system modulators
|
US10221454B2
(en)
|
2011-10-10 |
2019-03-05 |
The Hospital For Sick Children |
Methods and compositions for screening and treating developmental disorders
|
AU2012326137B2
(en)
|
2011-10-17 |
2018-11-29 |
Minerva Biotechnologies Corporation |
Media for stem cell proliferation and induction
|
CA2851795C
(en)
|
2011-10-20 |
2018-11-13 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Anti-cd22 chimeric antigen receptors
|
JP2014534864A
(ja)
|
2011-10-28 |
2014-12-25 |
プレサージュ バイオサイエンシズ,インコーポレイテッド |
薬物デリバリー方法
|
US11180807B2
(en)
|
2011-11-04 |
2021-11-23 |
Population Bio, Inc. |
Methods for detecting a genetic variation in attractin-like 1 (ATRNL1) gene in subject with Parkinson's disease
|
MX359234B
(es)
|
2011-11-11 |
2018-09-20 |
Hutchinson Fred Cancer Res |
Inmunoterapia de celulas t objetivadas en ciclina a1 para cancer.
|
WO2013082275A1
(en)
|
2011-11-30 |
2013-06-06 |
Trustees Of Boston College |
Inhibitors of phosphodiesterases 11 (pde11) and methods of use to elevate cortisol production
|
AU2012346214B2
(en)
|
2011-11-30 |
2017-09-14 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
ES2729967T3
(es)
|
2012-02-07 |
2019-11-07 |
Infectious Disease Res Inst |
Formulaciones de adyuvante mejoradas que comprenden agonistas de TLR4 y métodos para usar las mismas
|
DK2812452T3
(da)
|
2012-02-09 |
2020-06-29 |
Population Bio Inc |
Fremgangsmåder og sammensætninger til screening og behandling af udviklingsforstyrrelser
|
CN103251941A
(zh)
*
|
2012-02-16 |
2013-08-21 |
海南大学 |
动物病毒性疫苗脉冲释放系统、其制备方法及用途
|
CN110201003A
(zh)
|
2012-02-29 |
2019-09-06 |
伊西康内外科公司 |
微生物区系的组合物及与其相关的方法
|
US20130236484A1
(en)
|
2012-03-08 |
2013-09-12 |
Detectogen Inc. |
Leishmaniasis antigen detection assays and vaccines
|
CA3116051C
(en)
|
2012-03-23 |
2023-09-26 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Anti-mesothelin chimeric antigen receptors
|
US10130714B2
(en)
|
2012-04-14 |
2018-11-20 |
Academia Sinica |
Enhanced anti-influenza agents conjugated with anti-inflammatory activity
|
EP3505537A1
(en)
|
2012-05-07 |
2019-07-03 |
Trustees of Dartmouth College |
Anti-b7-h6 antibody, fusion proteins, and methods of using the same
|
EP3388835B1
(en)
|
2012-05-16 |
2020-04-01 |
Immune Design Corp. |
Vaccines for hsv-2
|
EP2877198A4
(en)
|
2012-07-11 |
2016-04-13 |
Univ Vermont |
METHOD AND COMPOSITION FOR METABOLIC REFORMULATION
|
KR101835401B1
(ko)
|
2012-07-13 |
2018-03-08 |
신 니뽄 바이오메디칼 라보라토리즈, 엘티디. |
키랄 핵산 어쥬번트
|
CA2880701A1
(en)
|
2012-08-18 |
2014-02-27 |
Academia Sinica |
Cell-permeable probes for identification and imaging of sialidases
|
WO2014031649A1
(en)
|
2012-08-21 |
2014-02-27 |
Genesys Research Institute |
Compositions and methods for treating or preventing anthracycline induced cardiotoxicity
|
EP2895621B1
(en)
|
2012-09-14 |
2020-10-21 |
Population Bio, Inc. |
Methods and compositions for diagnosing, prognosing, and treating neurological conditions
|
US10233495B2
(en)
|
2012-09-27 |
2019-03-19 |
The Hospital For Sick Children |
Methods and compositions for screening and treating developmental disorders
|
US9228184B2
(en)
|
2012-09-29 |
2016-01-05 |
Dynavax Technologies Corporation |
Human toll-like receptor inhibitors and methods of use thereof
|
EP3795694A3
(en)
|
2012-10-02 |
2021-06-23 |
The General Hospital Corporation d/b/a Massachusetts General Hospital |
Methods relating to dna-sensing pathway related conditions
|
BR112015009003B1
(pt)
|
2012-10-24 |
2023-01-31 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Receptores de antígeno quiméricos que se ligam especificamente a cd22, ácido nucleico, vetor de expressão recombinante, microrganismo transgênico, composição farmacêutica, e uso dos mesmos
|
US10106778B2
(en)
|
2012-11-08 |
2018-10-23 |
Whitehead Institute For Biomedical Research |
Selective targeting of cancer stem cells
|
EP2931273A1
(en)
|
2012-12-12 |
2015-10-21 |
The Charlotte-Mecklenburg Hospital Authority D/B/A Carolinas Healthcare System |
Methods of treating portal hypertension
|
EP2931272A1
(en)
|
2012-12-12 |
2015-10-21 |
The Charlotte-Mecklenburg Hospital Authority D/B/A Carolinas Healthcare System |
Methods of treating hepatic fibrosis and associated diseases by regulating rev-erb activity
|
EP2958586B1
(en)
|
2013-02-21 |
2018-09-05 |
Boehringer Ingelheim Vetmedica GmbH |
H5 proteins of h5n1 influenza virus for use as a medicament
|
RU2015143995A
(ru)
|
2013-03-14 |
2017-04-20 |
Халлюкс, Инк. |
Способ лечения инфекций, заболеваний или расстройств ногтевого ложа
|
JP6457999B2
(ja)
|
2013-03-14 |
2019-01-23 |
ザ チルドレンズ メディカル センター コーポレーション |
処置に関してがんの対象を識別するためのcd36の使用
|
US11376329B2
(en)
|
2013-03-15 |
2022-07-05 |
Trustees Of Tufts College |
Low molecular weight silk compositions and stabilizing silk compositions
|
CA2905090C
(en)
|
2013-03-15 |
2022-10-25 |
Trustees Of Tufts College |
Low molecular weight silk compositions and stabilizing silk compositions
|
US9790282B2
(en)
|
2013-03-25 |
2017-10-17 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Anti-CD276 polypeptides, proteins, and chimeric antigen receptors
|
JP2016522165A
(ja)
|
2013-04-04 |
2016-07-28 |
イエオ−イスティトゥート・エウロペオ・ディ・オンコロジア・エッセ・エッレ・エッレ |
胸腺間質性リンパ球新生因子フラグメント及びその使用
|
CN105209047B
(zh)
|
2013-04-18 |
2020-08-18 |
免疫设计股份有限公司 |
用于癌症治疗的gla单一疗法
|
EP2994758B1
(en)
|
2013-05-08 |
2017-12-20 |
Opthea Limited |
Biomarkers for age-related macular degeneration (amd)
|
US9463198B2
(en)
|
2013-06-04 |
2016-10-11 |
Infectious Disease Research Institute |
Compositions and methods for reducing or preventing metastasis
|
JP6785653B2
(ja)
|
2013-06-25 |
2020-11-18 |
ザ・ウォルター・アンド・エリザ・ホール・インスティテュート・オブ・メディカル・リサーチ |
細胞内感染の処置方法
|
US10086054B2
(en)
|
2013-06-26 |
2018-10-02 |
Academia Sinica |
RM2 antigens and use thereof
|
US9981030B2
(en)
|
2013-06-27 |
2018-05-29 |
Academia Sinica |
Glycan conjugates and use thereof
|
US10231993B2
(en)
|
2013-06-27 |
2019-03-19 |
University Of Washington Through Its Center For Commercialization |
Biocompatible polymeric system for targeted treatment of thrombotic and hemostatic disorders
|
WO2015006543A1
(en)
|
2013-07-10 |
2015-01-15 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Method for predicting and detecting tumor metastasis in kidney cancer
|
US10208125B2
(en)
|
2013-07-15 |
2019-02-19 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Anti-mucin 1 binding agents and uses thereof
|
US10633714B2
(en)
|
2013-07-21 |
2020-04-28 |
Pendulum Therapeutics, Inc. |
Methods and systems for microbiome characterization, monitoring and treatment
|
KR102298172B1
(ko)
|
2013-09-06 |
2021-09-06 |
아카데미아 시니카 |
변화된 글리코실 그룹을 갖는 당지질을 사용한 인간 iNKT 세포 활성화
|
CN105828833A
(zh)
|
2013-10-21 |
2016-08-03 |
萨克生物研究学院 |
突变的成纤维细胞生长因子(fgf)1及使用方法
|
KR101977449B1
(ko)
|
2013-11-01 |
2019-05-10 |
유니버시티에트 이 오슬로 |
알부민 변이체 및 이의 용도
|
US11452767B2
(en)
|
2013-11-15 |
2022-09-27 |
Oslo Universitetssykehus Hf |
CTL peptide epitopes and antigen-specific t cells, methods for their discovery, and uses thereof
|
RU2701346C1
(ru)
|
2013-12-06 |
2019-09-25 |
Дзе Юнайтед Стейтс Оф Америка, Эз Репрезентед Бай Дзе Секретари, Департмент Оф Хелс Энд Хьюман Сёрвисез |
Химерные антигенные рецепторы, специфичные в отношении рецептора тимусного стромального лимфопоэтина, и способы их применения
|
US10513546B2
(en)
|
2013-12-18 |
2019-12-24 |
President And Fellows Of Harvard College |
CRP capture/detection of gram positive bacteria
|
EP3083583B1
(en)
|
2013-12-20 |
2020-11-18 |
Sagimet Biosciences Inc. |
Heterocyclic modulators of lipid synthesis and combinations thereof
|
NZ721780A
(en)
|
2014-01-07 |
2022-01-28 |
Sagimet Biosciences Inc |
Heterocyclic modulators of lipid synthesis for use against cancer and viral infections
|
WO2015108048A1
(ja)
|
2014-01-15 |
2015-07-23 |
株式会社新日本科学 |
抗腫瘍作用を有するキラル核酸アジュバンド及び抗腫瘍剤
|
US10322173B2
(en)
|
2014-01-15 |
2019-06-18 |
Shin Nippon Biomedical Laboratories, Ltd. |
Chiral nucleic acid adjuvant having anti-allergic activity, and anti-allergic agent
|
EP3095461A4
(en)
|
2014-01-15 |
2017-08-23 |
Shin Nippon Biomedical Laboratories, Ltd. |
Chiral nucleic acid adjuvant having immunity induction activity, and immunity induction activator
|
US10150818B2
(en)
|
2014-01-16 |
2018-12-11 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
WO2015109180A2
(en)
|
2014-01-16 |
2015-07-23 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
MX2016009464A
(es)
|
2014-01-21 |
2017-01-16 |
Immune Design Corp |
Composiciones para el uso en el tratamiento de afecciones alergicas.
|
US20170224805A1
(en)
|
2014-02-20 |
2017-08-10 |
Vaxart, Inc. |
Formulations for small intestinal delivery
|
JP6772065B2
(ja)
|
2014-02-28 |
2020-10-21 |
バイエル・アニマル・ヘルス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングBayer Animal Health Gmbh |
免疫賦活プラスミド
|
EP3117004A4
(en)
|
2014-03-14 |
2017-12-06 |
University of Washington |
Genomic insulator elements and uses thereof
|
CA2943802A1
(en)
|
2014-03-26 |
2015-10-01 |
Children's Medical Center Corporation |
Cyclic prosaposin peptides and uses thereof
|
EP3129767B1
(en)
|
2014-03-27 |
2021-09-01 |
Academia Sinica |
Reactive labelling compounds and uses thereof
|
CN113403338A
(zh)
|
2014-03-28 |
2021-09-17 |
华盛顿大学商业中心 |
乳腺癌和卵巢癌疫苗
|
US10398672B2
(en)
|
2014-04-29 |
2019-09-03 |
Whitehead Institute For Biomedical Research |
Methods and compositions for targeting cancer stem cells
|
US11918695B2
(en)
|
2014-05-09 |
2024-03-05 |
Yale University |
Topical formulation of hyperbranched polymer-coated particles
|
EP3139909A4
(en)
|
2014-05-09 |
2018-01-03 |
Yale University |
Topical formulation of hyperbranched polyglycerol-coated particles thereof
|
CN107074945B
(zh)
|
2014-05-27 |
2021-08-24 |
中央研究院 |
增进抗体功效的通用糖型的组合物及方法
|
US10118969B2
(en)
|
2014-05-27 |
2018-11-06 |
Academia Sinica |
Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
|
CA2950415A1
(en)
|
2014-05-27 |
2015-12-03 |
Academia Sinica |
Anti-cd20 glycoantibodies and uses thereof
|
WO2015184002A1
(en)
|
2014-05-27 |
2015-12-03 |
Academia Sinica |
Anti-her2 glycoantibodies and uses thereof
|
WO2015184001A1
(en)
|
2014-05-28 |
2015-12-03 |
Academia Sinica |
Anti-tnf-alpha glycoantibodies and uses thereof
|
US10759836B2
(en)
|
2014-07-18 |
2020-09-01 |
University Of Washington |
Cancer vaccine compositions and methods of use thereof
|
US20170275287A1
(en)
|
2014-08-22 |
2017-09-28 |
Janus Biotherapeutics, Inc. |
Novel n2, n4, n7, 6-tetrasubstituted pteridine-2,4,7-triamine and 2, 4, 6, 7-tetrasubstituted pteridine compounds and methods of synthesis and use thereof
|
GB2558326B
(en)
|
2014-09-05 |
2021-01-20 |
Population Bio Inc |
Methods and compositions for inhibiting and treating neurological conditions
|
WO2016040369A2
(en)
|
2014-09-08 |
2016-03-17 |
Academia Sinica |
HUMAN iNKT CELL ACTIVATION USING GLYCOLIPIDS
|
CA2961609C
(en)
|
2014-09-17 |
2023-03-21 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Anti-cd276 antibodies (b7h3)
|
WO2016054240A1
(en)
|
2014-09-30 |
2016-04-07 |
Sean Dalziel |
Fixed dose combinations for the treatment of viral diseases
|
ES2924988T3
(es)
|
2014-10-10 |
2022-10-13 |
Univ Michigan Regents |
Composiciones con nanoemulsiones para prevenir, inhibir o eliminar una enfermedad alérgica e inflamatoria
|
WO2016061199A2
(en)
|
2014-10-14 |
2016-04-21 |
Research Development Foundation |
Methods for generating engineered enzymes
|
SG10201903823QA
(en)
|
2014-10-31 |
2019-05-30 |
Whole Biome Inc |
Methods and compositions relating to microbial treatment and diagnosis of disorders
|
WO2016079527A1
(en)
|
2014-11-19 |
2016-05-26 |
Tetralogic Birinapant Uk Ltd |
Combination therapy
|
WO2016097773A1
(en)
|
2014-12-19 |
2016-06-23 |
Children's Cancer Institute |
Therapeutic iap antagonists for treating proliferative disorders
|
US10495645B2
(en)
|
2015-01-16 |
2019-12-03 |
Academia Sinica |
Cancer markers and methods of use thereof
|
US9975965B2
(en)
|
2015-01-16 |
2018-05-22 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
JP6779887B2
(ja)
|
2015-01-24 |
2020-11-04 |
アカデミア シニカAcademia Sinica |
新規なグリカンコンジュゲートおよびその使用方法
|
CN107660213B
(zh)
|
2015-02-10 |
2023-01-13 |
米纳瓦生物技术公司 |
人源化抗MUCl*抗体
|
WO2016134110A1
(en)
|
2015-02-18 |
2016-08-25 |
University Of Vermont And State Agricultural College |
Mcj agonists and uses therefor
|
CN107530416A
(zh)
|
2015-03-05 |
2018-01-02 |
西北大学 |
非神经侵染的病毒及其用途
|
CN107428728A
(zh)
|
2015-03-19 |
2017-12-01 |
3-V生物科学股份有限公司 |
脂质合成的杂环调节剂
|
WO2016154585A1
(en)
|
2015-03-26 |
2016-09-29 |
Charles Sentman |
Anti-mica antigen binding fragments, fusion molecules, cells which express and methods of using
|
US10718022B2
(en)
|
2015-04-15 |
2020-07-21 |
University Of Massachusetts |
Compositions and methods for XI chromosome reactivation
|
RU2017140778A
(ru)
|
2015-04-25 |
2019-05-27 |
Дзе Дженерал Хоспитал Корпорейшн |
Комбинированная терапия антифугетактическим средством и противораковым средством, и композиции для лечения рака
|
BR112017026209A2
(pt)
|
2015-06-05 |
2018-11-27 |
Ibio, Inc. |
fragmentos e variantes de endostatinas para uso no tratamento de fibrose
|
CN118045170A
(zh)
|
2015-06-12 |
2024-05-17 |
瓦克萨特公司 |
用于rsv和诺如病毒抗原的小肠递送的制剂
|
EP3831844B1
(en)
|
2015-06-26 |
2024-03-13 |
Prindex S.r.l. |
Diagnosis and therapy of multiple sclerosis
|
CA2991911A1
(en)
|
2015-07-10 |
2017-01-19 |
University Of Vermont And State Agricultural College |
Methods and compositions to treat drug-induced diseases and conditions
|
CA2993883A1
(en)
|
2015-07-31 |
2017-02-09 |
Bayer Animal Health Gmbh |
Enhanced immune response in porcine species
|
WO2017024114A1
(en)
|
2015-08-06 |
2017-02-09 |
President And Fellows Of Harvard College |
Improved microbe-binding molecules and uses thereof
|
ES2876930T3
(es)
|
2015-08-20 |
2021-11-15 |
Asociacion Centro De Investig Cooperativa En Biociencias Cic Biogune |
Métodos y composiciones para tratar enfermedades y afecciones hepáticas
|
US11819554B2
(en)
|
2015-09-17 |
2023-11-21 |
University Of Massachusetts |
Compositions and methods for modulating FMR1 expression
|
CA2999083A1
(en)
|
2015-09-18 |
2017-03-23 |
The General Hospital Corporation Dba Massachusetts General Hospital |
Localized delivery of anti-fugetactic agent for treatment of cancer
|
US11352426B2
(en)
|
2015-09-21 |
2022-06-07 |
Aptevo Research And Development Llc |
CD3 binding polypeptides
|
CA3007301A1
(en)
|
2015-12-04 |
2017-06-08 |
Board Of Regents, The University Of Texas System |
Slc45a2 peptides for immunotherapy
|
EP3405496B1
(en)
|
2016-01-20 |
2023-10-25 |
University of Florida Research Foundation, Incorporated |
Ror1 antibody compositions and related methods
|
JP2019509023A
(ja)
|
2016-01-20 |
2019-04-04 |
ザ・スクリップス・リサーチ・インスティテュート |
Ror2抗体組成物及び関連する方法
|
AU2017221424A1
(en)
|
2016-02-16 |
2018-09-20 |
Yale University |
Compositions and methods for treatment of cystic fibrosis
|
US11136597B2
(en)
|
2016-02-16 |
2021-10-05 |
Yale University |
Compositions for enhancing targeted gene editing and methods of use thereof
|
WO2017156192A1
(en)
|
2016-03-08 |
2017-09-14 |
Academia Sinica |
Methods for modular synthesis of n-glycans and arrays thereof
|
WO2017173334A1
(en)
|
2016-04-01 |
2017-10-05 |
Checkmate Pharmaceuticals, Inc. |
Fc receptor-mediated drug delivery
|
CN109414489B
(zh)
|
2016-04-08 |
2022-08-16 |
埃缇健康公司D/B/A泽尔拜尔 |
网蛋白-1结合抗体及其用途
|
CN109415445A
(zh)
|
2016-05-04 |
2019-03-01 |
阿比利塔生物公司 |
用于制备多跨膜蛋白的方法和平台
|
EP4112638A1
(en)
|
2016-05-16 |
2023-01-04 |
Access to Advanced Health Institute |
Formulation containing tlr agonist and methods of use
|
JP7195147B2
(ja)
|
2016-05-16 |
2022-12-23 |
アクセス ツー アドバンスト ヘルス インスティチュート |
Peg化リポソームおよび使用方法
|
WO2017207623A1
(en)
|
2016-05-31 |
2017-12-07 |
Université de Lausanne |
Mirna as biomarkers and regulators of cancer stem cells
|
MX2018014399A
(es)
|
2016-06-01 |
2019-06-06 |
Infectious Disease Res Inst |
Particulas de nanoalumbre que contienen un agente de dimensionamiento.
|
US20190322643A1
(en)
|
2016-06-29 |
2019-10-24 |
Georgia State University Research Foundation, Inc. |
Histone deacetylase and histone methyltransferase inhibitors and methods of making and use of the same
|
WO2018005759A1
(en)
|
2016-07-01 |
2018-01-04 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Inhibitor of heme degradation for use to improve antibiotic treatment of mycobacterium tuberculosis infection
|
TWI759317B
(zh)
|
2016-07-26 |
2022-04-01 |
德商拜耳動物保健有限公司 |
牛物種中增加的生育力
|
JP7213549B2
(ja)
|
2016-08-22 |
2023-01-27 |
シーエイチオー ファーマ インコーポレイテッド |
抗体、結合性断片、および使用の方法
|
US11453706B2
(en)
|
2016-09-09 |
2022-09-27 |
The General Hospital Corporation |
HSP fusion protein with anti-chemorepellant agent for treatment of infectious disease
|
WO2018049120A1
(en)
|
2016-09-09 |
2018-03-15 |
The General Hospital Corporation |
Ex vivo antigen-presenting cells or activated cd-positive t cells for treatment of cancer
|
EP3509609A4
(en)
|
2016-09-09 |
2021-01-20 |
The General Hospital Corporation |
HYBRID HSP PROTEIN WITH ANTI-CHEMIO-REPELLENT AGENT FOR CANCER TREATMENT
|
WO2018063472A1
(en)
|
2016-09-27 |
2018-04-05 |
Reyoung Corporation |
Compositions for treating parasitic diseases and methods thereof
|
US11725232B2
(en)
|
2016-10-31 |
2023-08-15 |
The Hong Kong University Of Science And Technology |
Compositions, methods and kits for detection of genetic variants for alzheimer's disease
|
JP7231226B2
(ja)
|
2016-11-07 |
2023-03-01 |
ユニバーシティ オブ マサチューセッツ |
顔面肩甲上腕型筋ジストロフィーのための治療標的
|
WO2018096396A1
(en)
|
2016-11-22 |
2018-05-31 |
University Of Oslo |
Albumin variants and uses thereof
|
US10240205B2
(en)
|
2017-02-03 |
2019-03-26 |
Population Bio, Inc. |
Methods for assessing risk of developing a viral disease using a genetic test
|
WO2018145109A1
(en)
|
2017-02-06 |
2018-08-09 |
Massachusetts Institute Of Technology |
Methods and products related to glutaminase inhibitors
|
JP2020515542A
(ja)
|
2017-03-23 |
2020-05-28 |
ザ ジェネラル ホスピタル コーポレイション |
Cxcr4/cxcr7の遮断およびヒトパピローマウイルス関連疾患の治療
|
CA3057972A1
(en)
|
2017-03-27 |
2018-10-04 |
Tenfold Technologies, LLC |
Methods and agricultural compositions for preventing or controlling plant diseases
|
WO2018187493A1
(en)
|
2017-04-04 |
2018-10-11 |
Yale University |
Compositions and methods for in utero delivery
|
US11225512B2
(en)
|
2017-04-27 |
2022-01-18 |
University Of New Hampshire |
Compositions and methods for ceramide-elevating therapeutic strategies
|
US11390683B2
(en)
|
2017-05-18 |
2022-07-19 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Anti-mesothelin polypeptides and proteins
|
SG11201911930SA
(en)
|
2017-06-11 |
2020-01-30 |
Molecular Express Inc |
Methods and compositions for substance use disorder vaccine formulations and uses thereof
|
WO2018232257A1
(en)
|
2017-06-15 |
2018-12-20 |
Infectious Disease Research Institute |
Nanostructured lipid carriers and stable emulsions and uses thereof
|
WO2019009813A2
(en)
|
2017-07-06 |
2019-01-10 |
National University Of Singapore |
METHODS OF INHIBITING CELL PROLIFERATION AND METTL8 ACTIVITY
|
GB201710973D0
(en)
|
2017-07-07 |
2017-08-23 |
Avacta Life Sciences Ltd |
Scaffold proteins
|
AU2018301500A1
(en)
|
2017-07-14 |
2020-01-30 |
University Of Bath |
Methods and compositions for treating inflammation
|
EP3655437A1
(en)
|
2017-07-20 |
2020-05-27 |
NBE-Therapeutics AG |
Human antibodies binding to ror2
|
SG11202000846WA
(en)
|
2017-08-07 |
2020-02-27 |
Nbe Therapeutics Ag |
Anthracycline-based antibody drug conjugates having high in vivo tolerability
|
WO2019046646A1
(en)
|
2017-08-30 |
2019-03-07 |
Whole Biome Inc. |
METHODS AND COMPOSITIONS FOR THE TREATMENT OF MICROBIOMA ASSOCIATED DISORDERS
|
US12005112B2
(en)
|
2017-09-07 |
2024-06-11 |
University Of Oslo |
Vaccine molecules
|
WO2019048928A1
(en)
|
2017-09-07 |
2019-03-14 |
University Of Oslo |
VACCINE MOLECULES
|
WO2019108656A1
(en)
|
2017-11-28 |
2019-06-06 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Microbicidal composition
|
WO2019154884A1
(en)
|
2018-02-07 |
2019-08-15 |
Ecole Polytechnique Federale De Lausanne (Epfl) |
Method for determining cancer invasiveness and patient prognosis
|
WO2019156565A1
(en)
|
2018-02-12 |
2019-08-15 |
Fast Forward Pharmaceuticals B.V. |
Improved antagonistic anti-human cd40 monoclonal antibodies
|
WO2019204154A1
(en)
|
2018-04-18 |
2019-10-24 |
Reyoung Corporation |
Compositions and methods for treating liver cancer
|
JP7411315B2
(ja)
|
2018-04-19 |
2024-01-11 |
トゥヴァルディ セラピューティクス,インク. |
Stat3阻害剤
|
WO2019217164A1
(en)
|
2018-05-09 |
2019-11-14 |
Reyoung Corporation |
Compositions and methods for treating cancer and other diseases
|
MX2020013236A
(es)
|
2018-06-06 |
2021-02-22 |
Massachusetts Inst Technology |
Acido ribonucleico (arn) circular para traduccion en celulas eucariotas.
|
WO2020001657A1
(en)
|
2018-06-29 |
2020-01-02 |
Wuhan Neurophth Biological Technology Limited Company |
Compositions and methods for treating leber's hereditary optic neuropathy
|
KR20240014102A
(ko)
|
2018-06-29 |
2024-01-31 |
우한 뉴로프스 바이오테크놀로지 리미티드 컴퍼니 |
레버 유전성 시신경병증의 치료를 위한 조성물 및 방법
|
HRP20221504T1
(hr)
|
2018-08-08 |
2023-03-31 |
Pml Screening, Llc |
Postupci procjene rizika od razvoja progresivne multifokalne leukoencefalopatije uzrokovane john cunningham virusom pomoću genetskog testiranja
|
AU2019323434A1
(en)
|
2018-08-20 |
2021-02-25 |
Wuhan Neurophth Biotechnology Limited Company |
Compositions and methods for treating leber's hereditary optic neuropathy
|
US20210338815A1
(en)
|
2018-08-31 |
2021-11-04 |
Yale University |
Compositions and methods for enhancing triplex and nuclease-based gene editing
|
CN112930399A
(zh)
|
2018-08-31 |
2021-06-08 |
耶鲁大学 |
用于增强基于供体寡核苷酸的基因编辑的组合物和方法
|
WO2020051766A1
(zh)
|
2018-09-11 |
2020-03-19 |
上海市公共卫生临床中心 |
一种广谱抗流感疫苗免疫原及其应用
|
US11266617B2
(en)
|
2018-10-16 |
2022-03-08 |
Massachusetts Institute Of Technology |
Beta-hydroxybutyrate encapsulated PLGA nanoparticle compositions
|
CA3116762A1
(en)
|
2018-10-19 |
2020-04-23 |
Board Of Regents, The University Of Texas System |
Engineered long interspersed element (line) transposons and methods of use thereof
|
WO2020102454A1
(en)
|
2018-11-13 |
2020-05-22 |
Regents Of The University Of Minnesota |
Cd40 targeted peptides and uses thereof
|
EP3883562A4
(en)
|
2018-11-21 |
2022-08-03 |
Tremeau Pharmaceuticals, Inc. |
PURIFIED FORMS OF ROFECOXIB AND METHODS OF MAKING AND USING
|
EP3677693A1
(en)
|
2019-01-03 |
2020-07-08 |
Ecole Polytechnique Federale De Lausanne (EPFL) EPFL-TTO |
Transpochimeric gene trancripts (tcgts) as cancer biomarkers
|
BR112021013824A2
(pt)
|
2019-01-18 |
2021-12-14 |
Janssen Biotech Inc |
Receptores de antígeno quiméricos gprc5d e células que expressam os mesmos
|
AU2020215177A1
(en)
|
2019-01-30 |
2021-08-12 |
Janssen Pharmaceutica Nv |
Methods of treating prostate cancer based on molecular subtypes
|
WO2020186187A1
(en)
|
2019-03-13 |
2020-09-17 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Methods for treating bladder and urethra dysfunction and disease
|
EP3923989A1
(en)
|
2019-03-21 |
2021-12-22 |
Mitotherapeutix LLC |
Multivalent ligand clusters for targeted delivery of therapeutic agents
|
CA3136618A1
(en)
|
2019-04-10 |
2020-10-15 |
Elevatebio Technologies, Inc. |
Flt3-specific chimeric antigen receptors and methods of using the same
|
BR112021023411A2
(pt)
|
2019-05-22 |
2022-02-01 |
Massachusetts Inst Technology |
Composições e métodos de rna circular
|
WO2020239478A1
(en)
|
2019-05-28 |
2020-12-03 |
Pharma Mar, S.A. |
Trabectedin for treating sarcomas based on genomic markers
|
US20220372474A1
(en)
|
2019-06-21 |
2022-11-24 |
Yale University |
Hydroxymethyl-modified gamma-pna compositions and methods of use thereof
|
WO2020257776A1
(en)
|
2019-06-21 |
2020-12-24 |
Yale University |
Peptide nucleic acid compositions with modified hoogsteen binding segments and methods of use thereof
|
CN114364402A
(zh)
|
2019-07-15 |
2022-04-15 |
罗瓦萨公司 |
用于治疗癌症的阿片类生长因子受体(ogfr)拮抗剂,特别是纳洛酮和/或纳曲酮
|
EP4004057A1
(en)
|
2019-07-26 |
2022-06-01 |
Janssen Biotech, Inc. |
Proteins comprising kallikrein related peptidase 2 antigen binding domains and their uses
|
TW202118792A
(zh)
|
2019-07-26 |
2021-05-16 |
美商健生生物科技公司 |
抗hk2嵌合抗原受體(car)
|
WO2021022161A1
(en)
|
2019-07-31 |
2021-02-04 |
Yale University |
Compositions and methods for treating sickle cell disease
|
MX2022001732A
(es)
|
2019-08-12 |
2022-05-06 |
Purinomia Biotech Inc |
Metodos y composiciones para promover y potenciar la respuesta inmunitaria mediada por linfocitos t dirigida a la adcc de las celulas con expresion de cd39.
|
CN112390894A
(zh)
|
2019-08-12 |
2021-02-23 |
广东东阳光药业有限公司 |
嵌合抗原受体及其应用
|
AU2020334317A1
(en)
|
2019-08-16 |
2022-04-07 |
Janssen Biotech, Inc. |
Therapeutic immune cells with improved function and methods for making the same
|
US20230227583A1
(en)
|
2019-08-30 |
2023-07-20 |
Yale University |
Compositions and methods for delivery of nucleic acids to cells
|
TW202128775A
(zh)
|
2019-10-16 |
2021-08-01 |
英商阿法克塔生命科學有限公司 |
PD-L1抑制劑-TGFβ抑制劑雙特異性藥物部分
|
US10945992B1
(en)
|
2019-11-13 |
2021-03-16 |
Tremeau Pharmaceuticals, Inc. |
Dosage forms of rofecoxib and related methods
|
MX2022005983A
(es)
|
2019-11-18 |
2022-09-07 |
Janssen Biotech Inc |
Receptores del antígeno quimérico anti-cd79, células car-t, y usos de estos.
|
CN113025633A
(zh)
|
2019-12-09 |
2021-06-25 |
武汉纽福斯生物科技有限公司 |
编码人nadh脱氢酶亚单位1蛋白的核酸及其应用
|
EP3868396A1
(en)
|
2020-02-20 |
2021-08-25 |
Enthera S.R.L. |
Inhibitors and uses thereof
|
EP4107267A1
(en)
|
2020-02-21 |
2022-12-28 |
Mitotherapeutix LLC |
Compositions and methods for inhibiting expression of methylation-controlled j-protein (mcj)
|
IL302349A
(en)
|
2020-03-13 |
2023-06-01 |
Janssen Biotech Inc |
Materials and methods for binding SIGLEC-3/CD33
|
US20230181672A1
(en)
|
2020-05-07 |
2023-06-15 |
The U.S.A., As Represented By The Secretary, Department Of Health And Human Services |
Aberrant post-translational modifications (ptms) in methyl- and propionic acidemia and a mutant sirtuin (sirt) to metabolize ptms
|
CA3179423A1
(en)
|
2020-05-19 |
2021-11-25 |
Robert Alexander WESSELHOEFT |
Circular rna compositions and methods
|
US20230212256A1
(en)
|
2020-05-21 |
2023-07-06 |
Board Of Regents, The University Of Texas System |
T cell receptors with vgll1 specificity and uses thereof
|
WO2021245285A1
(en)
|
2020-06-05 |
2021-12-09 |
Janssen Pharmaceutica Nv |
Methods of treating prostate cancer based on molecular subtypes
|
GB202101299D0
(en)
|
2020-06-09 |
2021-03-17 |
Avacta Life Sciences Ltd |
Diagnostic polypetides and methods
|
AU2021331785A1
(en)
|
2020-08-31 |
2023-03-30 |
Gennao Bio, Inc. |
Compositions and methods for delivery of nucleic acids to cells
|
CA3173951A1
(en)
|
2020-09-04 |
2022-03-10 |
Emily VOIGT |
Genetically-adjuvanted rna vaccines
|
US20230338501A1
(en)
|
2020-09-04 |
2023-10-26 |
Access To Advanced Health Institute |
Live-attenuated rna hybrid vaccine technology
|
AU2021337493A1
(en)
|
2020-09-04 |
2023-05-18 |
Access To Advanced Health Institute |
Co-lyophilized rna and nanostructured lipid carrier
|
WO2022081895A1
(en)
|
2020-10-16 |
2022-04-21 |
University Of Georgia Research Foundation, Inc. |
Glycoconjugates
|
EP4059498A1
(en)
|
2021-03-16 |
2022-09-21 |
Centre Hospitalier Universitaire Vaudois (CHUV) |
Methods and compositions for treating conditions associated with hypermineralization
|
IL306103A
(en)
|
2021-03-24 |
2023-11-01 |
Janssen Biotech Inc |
The antibody targets CD22 and CD79B
|
US11161833B1
(en)
|
2021-04-09 |
2021-11-02 |
Tremeau Pharmaceuticals, Inc. |
Deuterated etoricoxib, methods of manufacture, and use thereof
|
WO2022234003A1
(en)
|
2021-05-07 |
2022-11-10 |
Avacta Life Sciences Limited |
Cd33 binding polypeptides with stefin a protein
|
WO2022237974A1
(en)
|
2021-05-12 |
2022-11-17 |
Ecole Polytechnique Federale De Lausanne (Epfl) |
Krab-containing zinc finger protein and cancer
|
CN115404240A
(zh)
|
2021-05-28 |
2022-11-29 |
上海环码生物医药有限公司 |
制备环形rna的构建体、方法及其用途
|
WO2022261115A1
(en)
|
2021-06-07 |
2022-12-15 |
Yale University |
Peptide nucleic acids for spatiotemporal control of crispr-cas binding
|
WO2022271955A1
(en)
|
2021-06-23 |
2022-12-29 |
Musc Foundation For Research Development |
Novel targeted shrna nanoparticles for cancer therapy
|
CN115927472A
(zh)
|
2021-07-05 |
2023-04-07 |
武汉纽福斯生物科技有限公司 |
一种抗vegf抗体体内表达系统的构建和应用
|
CN116024266A
(zh)
|
2021-08-06 |
2023-04-28 |
武汉纽福斯生物科技有限公司 |
用于治疗由于nd4突变造成的莱伯氏遗传性视神经病变的组合物和方法
|
WO2023046322A1
(en)
|
2021-09-24 |
2023-03-30 |
Janssen Pharmaceutica Nv |
Proteins comprising cd20 binding domains, and uses thereof
|
WO2023057567A1
(en)
|
2021-10-07 |
2023-04-13 |
Avacta Life Sciences Limited |
Pd-l1 binding affimers
|
TW202332694A
(zh)
|
2021-10-07 |
2023-08-16 |
英商阿凡克塔生命科學公司 |
血清半衰期延長之pd-l1結合多肽
|
TW202334080A
(zh)
|
2021-11-08 |
2023-09-01 |
美商歐納醫療公司 |
用於遞送環狀聚核苷酸之脂質奈米粒子組合物
|
CN116940682A
(zh)
|
2021-11-16 |
2023-10-24 |
上海舶望制药有限公司 |
抑制血管紧张素原(agt)蛋白表达的组合物和方法
|
WO2023218243A1
(en)
|
2022-05-12 |
2023-11-16 |
Avacta Life Sciences Limited |
Lag-3/pd-l1 binding fusion proteins
|
WO2023231959A2
(en)
|
2022-05-30 |
2023-12-07 |
Shanghai Circode Biomed Co., Ltd |
Synthetic circular rna compositions and methods of use thereof
|
WO2024052882A1
(en)
|
2022-09-09 |
2024-03-14 |
Access To Advanced Health Institute |
Immunogenic vaccine composition incorporating a saponin
|
WO2024055034A1
(en)
|
2022-09-09 |
2024-03-14 |
Yale University |
Proteolysis targeting antibodies and methods of use thereof
|
WO2024081736A2
(en)
|
2022-10-11 |
2024-04-18 |
Yale University |
Compositions and methods of using cell-penetrating antibodies
|
WO2024094526A1
(en)
|
2022-11-02 |
2024-05-10 |
Ecole Polytechnique Federale De Lausanne (Epfl) |
6-diazo-5-oxo-l-norleucine prodrugs
|
WO2024102762A1
(en)
|
2022-11-08 |
2024-05-16 |
Orna Therapeutics, Inc. |
Lipids and lipid nanoparticle compositions for delivering polynucleotides
|
WO2024102730A1
(en)
|
2022-11-08 |
2024-05-16 |
Orna Therapeutics, Inc. |
Lipids and nanoparticle compositions for delivering polynucleotides
|
WO2024129982A2
(en)
|
2022-12-15 |
2024-06-20 |
Orna Therapeutics, Inc. |
Circular rna compositions and methods
|
US11957676B1
(en)
|
2023-08-07 |
2024-04-16 |
Zetagen Therapeutics, Inc. |
Controlled release formulation and minimally invasive method of administration to locally treat cancer
|